nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
549: A biochemical, immunocytochemical, and bioinformatics analysis of the functional association between TBC domain-containing proteins and Rab G proteins
|
Faitar, S. |
|
2014 |
50 |
S5 |
p. S133- 1 p. |
artikel |
2 |
About AEK
|
|
|
2014 |
50 |
S5 |
p. xviii- 1 p. |
artikel |
3 |
About the EACR
|
|
|
2014 |
50 |
S5 |
p. xix- 1 p. |
artikel |
4 |
388: A building-block lentiviral vector system that facilitates combinatorial genetics and tumor modelling in primary cells and in mouse tissues
|
Albers, J. |
|
2014 |
50 |
S5 |
p. S92-S93 2 p. |
artikel |
5 |
971A: Carcinogenic and non-carcinogenic risk assessment of bis(2-ethylhexyl) phthalate in bottled water
|
Rastkari, N. |
|
2014 |
50 |
S5 |
p. S237- 1 p. |
artikel |
6 |
Accreditation Information
|
|
|
2014 |
50 |
S5 |
p. ix- 1 p. |
artikel |
7 |
730: ACK1 is a potential target for anti-metastasis therapeutic development
|
Chua, B.T. |
|
2014 |
50 |
S5 |
p. S175- 1 p. |
artikel |
8 |
Acknowledgements
|
|
|
2014 |
50 |
S5 |
p. vi- 1 p. |
artikel |
9 |
532: A combined transcriptional and proteomic approach to identification of SOX11 regulated pathways in mantle cell lymphoma
|
Kuci, V. |
|
2014 |
50 |
S5 |
p. S128-S129 2 p. |
artikel |
10 |
524: A c-Rel-NFATc2-COX2 pathway is critical for TRAIL resistance of pancreatic cancer cells
|
Geismann, C. |
|
2014 |
50 |
S5 |
p. S126- 1 p. |
artikel |
11 |
215: Activated B cell receptor signaling pathway contributes to bortezomib resistance in mantle cell lymphoma
|
Kim, A. |
|
2014 |
50 |
S5 |
p. S49- 1 p. |
artikel |
12 |
888: Activation and homing profile of dendritic cells in human colorectal cancer - effect of tumour derived factors or leaky lymph nodes?
|
Lee, G. |
|
2014 |
50 |
S5 |
p. S217- 1 p. |
artikel |
13 |
801: Activation of HER3 interferes with antitumor effects of Axl receptor tyrosine kinase inhibitors − suggestion of combination therapy
|
Torka, R. |
|
2014 |
50 |
S5 |
p. S193-S194 2 p. |
artikel |
14 |
874: Activation of systemic anti-tumor immunity by in situ ablation of breast carcinoma by intratumoral 224Ra-loaded wires
|
Confino, H. |
|
2014 |
50 |
S5 |
p. S213- 1 p. |
artikel |
15 |
497: Activation of TRKA receptor by nerve growth factor induces shedding of P75 receptor related with progression of epithelial ovarian cancer
|
Romero, C. |
|
2014 |
50 |
S5 |
p. S119-S120 2 p. |
artikel |
16 |
311: A CXCR4-positive subpopulation exhibits cancer stem cell properties in renal cell carcinoma
|
Zimmermann, W. |
|
2014 |
50 |
S5 |
p. S74- 1 p. |
artikel |
17 |
177: ADAM9 coordinates genes in anoikis resistance for lung cancer metastases
|
Sher, Y. |
|
2014 |
50 |
S5 |
p. S40- 1 p. |
artikel |
18 |
550: A functional Cav1-Fas interplay as a new mechanism of chemoresistance in colon cancer
|
Carbó, N. |
|
2014 |
50 |
S5 |
p. S133- 1 p. |
artikel |
19 |
446: A gain of function by the cancer-associated FGFR4 c.1162G>A (p.Gly388Arg) variant
|
Ulaganathan, V.K. |
|
2014 |
50 |
S5 |
p. S107-S108 2 p. |
artikel |
20 |
755: A gemcitabine prodrug for the treatment of castration-resistant prostate cancer: Reduced metabolic inactivation combined with targeted drug delivery
|
Karampelas, T. |
|
2014 |
50 |
S5 |
p. S182- 1 p. |
artikel |
21 |
857: Aggravation of ER stress by combination of proteasome inhibitors and HIV protease inhibitors results in preferencial killing of triple-negative breast cancer cells in vitro
|
Gibbons Marsico, J. |
|
2014 |
50 |
S5 |
p. S209- 1 p. |
artikel |
22 |
939: A highly polymorphic AG repeat in the upstream regulatory region of the estrogen-induced gene EIG121 is a modifier of disease risk in endometrial cancer
|
Bolton, K.A. |
|
2014 |
50 |
S5 |
p. S230- 1 p. |
artikel |
23 |
527: A hormone-dependent feedback-loop controls androgen receptor levels by limiting Midline1, a novel translation enhancer and promoter of oncogenic signaling
|
Demir, U. |
|
2014 |
50 |
S5 |
p. S127- 1 p. |
artikel |
24 |
495: AKT and gefitinib resistance in mutant KRAS non-small cell lung cancers through mechanisms dependent of acetylation
|
Jeannot, V. |
|
2014 |
50 |
S5 |
p. S119- 1 p. |
artikel |
25 |
502: AKT inhibition induces a prosurvival autophagy response that limits combination effects with gefitinib
|
Bokobza, S.M. |
|
2014 |
50 |
S5 |
p. S121- 1 p. |
artikel |
26 |
29: Alcohol and cancer risk, with focus on low doses
|
La Vecchia, C. |
|
2014 |
50 |
S5 |
p. S8- 1 p. |
artikel |
27 |
672: ALK fusion in a cohort of 469 Finnish patients with non-small cell lung cancer
|
Merkkiniemi, K. |
|
2014 |
50 |
S5 |
p. S237-S238 2 p. |
artikel |
28 |
876: Allergen induced pulmonary inflammation enhances mammary tumor growth and metastasis: Role of CHI3L1
|
Libreros, S. |
|
2014 |
50 |
S5 |
p. S214- 1 p. |
artikel |
29 |
279: Alterations of hepatocyte metabolic identity are triggered by the hepatitis C virus through systemic wnt/β-catenin signalling
|
Moreau, M. |
|
2014 |
50 |
S5 |
p. S66- 1 p. |
artikel |
30 |
408: AML mesenchymal stem cells signature
|
Oliveira, N. |
|
2014 |
50 |
S5 |
p. S97- 1 p. |
artikel |
31 |
463: A molecular study of breast cancer progression stages from normal breast tissue to invasive cancer
|
Bergholtz, H. |
|
2014 |
50 |
S5 |
p. S112- 1 p. |
artikel |
32 |
978: A multimarker panel for circulating tumor cells detection predicts patient outcome and therapy response in metastatic colorectal cancer
|
Barbazan, J. |
|
2014 |
50 |
S5 |
p. S238- 1 p. |
artikel |
33 |
912: Analysing the effects of radiotherapy on the metastatic phenotype: A role for combined therapeutic approaches incorporating Src and PI3K targeting
|
Rowling, E.J. |
|
2014 |
50 |
S5 |
p. S223- 1 p. |
artikel |
34 |
317: Analysis of HER2 amplification and IGF-IR expression in CETCs and its possible association with resistance to trastuzumab in HER2 positive breast cancers
|
Zimon, D. |
|
2014 |
50 |
S5 |
p. S76- 1 p. |
artikel |
35 |
500: Analysis of the metastasis/tumor-suppressing effects of SASH1
|
Nitsche, U. |
|
2014 |
50 |
S5 |
p. S120-S121 2 p. |
artikel |
36 |
114: An aqueous extract of Limoniastrum guyonianum gall induces anti-tumor effects in melanoma-injected mice via modulation of the immune response
|
Krifa, M. |
|
2014 |
50 |
S5 |
p. S26- 1 p. |
artikel |
37 |
651: An array-based pharmacogenetic study on elderly patients with advanced breast cancer treated with aromatase inhibitors
|
Rumiato, E. |
|
2014 |
50 |
S5 |
p. S155- 1 p. |
artikel |
38 |
273: Androgen receptor interacting protein HSPBAP1 facilitates growth of prostate cancer cells in androgen-deficient conditions
|
Ostling, P. |
|
2014 |
50 |
S5 |
p. S64- 1 p. |
artikel |
39 |
19: Aneuploidy and telomerase in stem cell derived cancer
|
Rudolph, K. |
|
2014 |
50 |
S5 |
p. S6- 1 p. |
artikel |
40 |
870: A new bispecific T cell recruiting antibody enhances anti-tumor activity of adoptive T cell transfer
|
Kobold, S. |
|
2014 |
50 |
S5 |
p. S213- 1 p. |
artikel |
41 |
871: A new PD1-CD28 chimeric receptor overcomes PD-1-mediated immunosuppression in adoptive T cell therapy
|
Kobold, S. |
|
2014 |
50 |
S5 |
p. S213- 1 p. |
artikel |
42 |
764: A new survival model for hyperthermic intraperitoneal chemoperfusion (HIPEC) in tumor-bearing rats in the treatment of advanced ovarian cancer
|
Kireeva, G.S. |
|
2014 |
50 |
S5 |
p. S183-S184 2 p. |
artikel |
43 |
433: An integrated multi level ‘-omics’ approach to decipher disease recurrence in epithelial ovarian cancer
|
Orsini, P. |
|
2014 |
50 |
S5 |
p. S104- 1 p. |
artikel |
44 |
369: An in vivo shRNA screen to identify novel drivers and therapeutic targets of breast cancer metastasis
|
Van Weverwijk, A. |
|
2014 |
50 |
S5 |
p. S88- 1 p. |
artikel |
45 |
105: Anoikis of colon carcinoma cells triggered by beta-catenin loss can be enhanced by Tumor Necrosis Factor Receptor 1 antagonists
|
Rosen, K. |
|
2014 |
50 |
S5 |
p. S24- 1 p. |
artikel |
46 |
228: A novel animal model of phaeochromocytoma for preclinical therapy evaluation
|
Ullrich, M. |
|
2014 |
50 |
S5 |
p. S53- 1 p. |
artikel |
47 |
135: A novel monoclonal antibody allowing for the isolation and analysis of Lgr5 positive cells from cell lines and primary human tissue
|
Agorku, D. |
|
2014 |
50 |
S5 |
p. S30- 1 p. |
artikel |
48 |
260: A novel MYC directed apoptosis pathway controls NOXA and BIM transcription
|
Wirth, M. |
|
2014 |
50 |
S5 |
p. S61- 1 p. |
artikel |
49 |
773: A novel pharmacological approach to inhibit Myc in cancer
|
Beaulieu, M.E. |
|
2014 |
50 |
S5 |
p. S186- 1 p. |
artikel |
50 |
769: A novel photodynamic therapy using mannose conjugated chlorin targeting cancer cells and tumor-associated macrophages
|
Hayashi, N. |
|
2014 |
50 |
S5 |
p. S184-S185 2 p. |
artikel |
51 |
905: A novel role of kaempferol: Enhancing the radiosensitivity on lung cancer cells
|
Yao, C. |
|
2014 |
50 |
S5 |
p. S221-S222 2 p. |
artikel |
52 |
985: A novel sampling device for collecting mucocellular material from the unprepared rectum
|
Booth, J. |
|
2014 |
50 |
S5 |
p. S240- 1 p. |
artikel |
53 |
844: A novel strategy for the treatment of Hodgkin lymphoma
|
Stolfa, D. |
|
2014 |
50 |
S5 |
p. S205- 1 p. |
artikel |
54 |
666: A novel zebrafish model of glioma reveals cell fate alteration through expression of oncogenic RAS
|
Spitzner, M. |
|
2014 |
50 |
S5 |
p. S159-S160 2 p. |
artikel |
55 |
170: A novel Zn(II)-compound reactivates mutant p53 protein in cancer cells: molecular mechanisms and therapeutical implications
|
Garufi, A. |
|
2014 |
50 |
S5 |
p. S38- 1 p. |
artikel |
56 |
752: Anti-cancer proteins found in amniotic membrane: extraction, identification and cellular effects
|
Mamede, A.C. |
|
2014 |
50 |
S5 |
p. S181- 1 p. |
artikel |
57 |
819: Anti-migratory and cytotoxic properties of medicinal plants against melanoma
|
Alqathama, A. |
|
2014 |
50 |
S5 |
p. S198- 1 p. |
artikel |
58 |
179: Antiproliferative effects of different fractions obtained from Anthemis nobilis leaves on human oral cancer cell
|
Salimi, M. |
|
2014 |
50 |
S5 |
p. S40- 1 p. |
artikel |
59 |
154: Antithetic effect of PDGFRbeta-induced miR-9 and ZEB-1-repressed miR-200cin vasculogenic mimicry of triple negative breast cancer
|
D’Ippolito, E. |
|
2014 |
50 |
S5 |
p. S34- 1 p. |
artikel |
60 |
137: Antitumor activities of some macrofungi extracts
|
Zizak, Z. |
|
2014 |
50 |
S5 |
p. S30-S31 2 p. |
artikel |
61 |
778: Anti-tumor activity of a novel monoclonal antibody recognizing claudin-3 and -4
|
Li, X. |
|
2014 |
50 |
S5 |
p. S187- 1 p. |
artikel |
62 |
846: Antitumor activity of the synthetic retinoid ST1926 in colorectal cancer cells: involvement of DNA damage
|
Darwiche, N. |
|
2014 |
50 |
S5 |
p. S206- 1 p. |
artikel |
63 |
281: A panel of 20 genes involved in cellular adhesion and ECM remodelling distinguishes renal cancer and control samples
|
Boguslawska, J. |
|
2014 |
50 |
S5 |
p. S66- 1 p. |
artikel |
64 |
708: A Phase Ib study of BKM120 combined with abiraterone acetate for castrate-resistant, metastatic prostate cancer
|
Patnaik, A. |
|
2014 |
50 |
S5 |
p. S171- 1 p. |
artikel |
65 |
250: Apoptosis and proliferation in micropapillary structures of colorectal polyps and carcinomas
|
Patankar, M. |
|
2014 |
50 |
S5 |
p. S59- 1 p. |
artikel |
66 |
255: Apoptosis-inducing effect of Usnea filipendula Stirt. in breast cancer cells in vitro
|
Sarimahmut, M. |
|
2014 |
50 |
S5 |
p. S60- 1 p. |
artikel |
67 |
465: A possible genetic signature of DNA repair genes in triple negative breast cancers by a NGS approach
|
Spugnesi, L. |
|
2014 |
50 |
S5 |
p. S112-S113 2 p. |
artikel |
68 |
774: A potent betulenic acid analogue induces apoptosis in HT29 cells
|
Dutta, D. |
|
2014 |
50 |
S5 |
p. S186- 1 p. |
artikel |
69 |
926: Application of texture analysis to SPECT images of 125I-A5B7 anti-CEA antibody localisation in metastatic colorectal cancer models: Correlation with histological microarchitecture and response to antivascular therapy
|
Rajkumar, V. |
|
2014 |
50 |
S5 |
p. S227- 1 p. |
artikel |
70 |
721: Aprepitant combinations (AC) for chemotherapy-induced nausea and vomiting (CINV) in adults: A meta-analysis of randomized controlled trials (RCTs)
|
Gupta, N. |
|
2014 |
50 |
S5 |
p. S173- 1 p. |
artikel |
71 |
271: AR-associated p21 induces apoptosis by neutralizing anti-apoptotic Bcl-2 protein in androgen-dependent prostate cancer LNCaP cells
|
Choi, K. |
|
2014 |
50 |
S5 |
p. S64- 1 p. |
artikel |
72 |
587: Are molecular findings of papillary thyroid microcarcinoma associated with its morphology?
|
Cacchi, C. |
|
2014 |
50 |
S5 |
p. S141-S142 2 p. |
artikel |
73 |
919: Arginine deprivation and radiation as combination therapy: A systematic study in HNSCC 2-D vs. 3-D culture models
|
Manig, F. |
|
2014 |
50 |
S5 |
p. S225- 1 p. |
artikel |
74 |
303: A role for senescent cell-derived IL6 in HER2+ breast cancer progression
|
Zacarias Fluck, M. |
|
2014 |
50 |
S5 |
p. S72- 1 p. |
artikel |
75 |
244: Aromatase expression contributes to the survival and metastasis of estrogen receptor positive breast cancer cells
|
Sun, L.Z. |
|
2014 |
50 |
S5 |
p. S57- 1 p. |
artikel |
76 |
560: Artemin promotes metastasis through p44/42 MAPK pathway in colorectal carcinoma
|
Zhuang, Q. |
|
2014 |
50 |
S5 |
p. S135- 1 p. |
artikel |
77 |
756: Ascorbic acid-induced cytotoxicity in colon cancer cell lines
|
Pires, A.S. |
|
2014 |
50 |
S5 |
p. S182- 1 p. |
artikel |
78 |
723: A sorafenib derivative and novel SHP-1 agonist, SC-59, acts synergistically with radiotherapy in hepatocellular carcinoma cells through inhibition of STAT3
|
Huang, C.Y. |
|
2014 |
50 |
S5 |
p. S174- 1 p. |
artikel |
79 |
514: Assessing functional ER pathway activity using a computational pathway model
|
Van de Wiel, P. |
|
2014 |
50 |
S5 |
p. S124- 1 p. |
artikel |
80 |
483: Assessment of fibroblast growth factor receptor 2 amplification in gastric cancer using quantitative real-time polymerase chain reaction, fluorescent in situ hybridization and immunohistochemistry
|
Park, Y.S. |
|
2014 |
50 |
S5 |
p. S116- 1 p. |
artikel |
81 |
962: Association of SULT1A1 Arg213His polymorphism with male breast cancer risk: a case−control study in Italy
|
Rizzolo, P. |
|
2014 |
50 |
S5 |
p. S234-S235 2 p. |
artikel |
82 |
784: A strategy to screen and subsequently identify therapeutically valuable microRNAs that target a clinically established KITENIN oncogene in colorectal cancer
|
Yoon, S.M. |
|
2014 |
50 |
S5 |
p. S189- 1 p. |
artikel |
83 |
608: A systematic approach to the metastatically relevant microRNA landscape
|
Mudduluru, G. |
|
2014 |
50 |
S5 |
p. S146-S147 2 p. |
artikel |
84 |
207: A tea polyphenol epigallocatechin gallate (EGCG) displays a superior effect on enzyme inhibition of human ornithine decarboxylase
|
Hung, H.C. |
|
2014 |
50 |
S5 |
p. S47- 1 p. |
artikel |
85 |
199: ATM kinase expression regulates breast cancer stem-like phenotype
|
Antonelli, M. |
|
2014 |
50 |
S5 |
p. S45- 1 p. |
artikel |
86 |
493: ATM kinase sustains HER2 tumorigenicity in breast cancer
|
Stagni, V. |
|
2014 |
50 |
S5 |
p. S118-S119 2 p. |
artikel |
87 |
650: Atypical nuclear localization of VIP receptors in glioma cell lines and patients
|
Barbarin, A. |
|
2014 |
50 |
S5 |
p. S155- 1 p. |
artikel |
88 |
720: Augmentation of NAD+ by NQO1 activation attenuates cisplatin-mediated hearing impairment
|
So, H. |
|
2014 |
50 |
S5 |
p. S173- 1 p. |
artikel |
89 |
120: Autocrine human growth hormone promotes the oncogenic behaviour of hepatocellular carcinoma cells
|
Chen, Y.J. |
|
2014 |
50 |
S5 |
p. S27- 1 p. |
artikel |
90 |
132: Autocrine human growth hormone suppression of E-cadherin via p44/42 MAPK promotes epithelial-to-mesenchymal transition of colorectal carcinoma cells
|
Wang, J. |
|
2014 |
50 |
S5 |
p. S29- 1 p. |
artikel |
91 |
626: Autophagosome-mediated EGFR down-regulation induced by CK2 inhibitor enhances the efficacy of EGFR-TKI on EGFR-mutant lung cancer cells with T790M
|
Lee, J. |
|
2014 |
50 |
S5 |
p. S149- 1 p. |
artikel |
92 |
39: Autophagy and cell death
|
Fulda, S. |
|
2014 |
50 |
S5 |
p. S10-S11 2 p. |
artikel |
93 |
125: Autophagy effects of pterostilbene on human oral cancer cells through modulation of Akt and mitogen-activated protein kinase pathway
|
Lin, C. |
|
2014 |
50 |
S5 |
p. S28- 1 p. |
artikel |
94 |
169: Autoschizis: a cell death induced by the anticancer, pro-oxidant stress of ascorbate:menadione combination
|
Gilloteaux, J. |
|
2014 |
50 |
S5 |
p. S38- 1 p. |
artikel |
95 |
969: Avoided cost in chemotherapy drugs attributable to patients inclusion in clinical trials
|
Sanchez, M. |
|
2014 |
50 |
S5 |
p. S236-S237 2 p. |
artikel |
96 |
Awards
|
|
|
2014 |
50 |
S5 |
p. xv-xvii nvt p. |
artikel |
97 |
14: Balancing energetic and anabolic needs of cancer cells
|
Vousden, K. |
|
2014 |
50 |
S5 |
p. S5- 1 p. |
artikel |
98 |
348: BCAT1 promotes cell proliferation through amino acid catabolism in gliomas carrying wild-type IDH1
|
Radlwimmer, B. |
|
2014 |
50 |
S5 |
p. S83- 1 p. |
artikel |
99 |
314: BCLAF1; a multi-faceted protein involved DNA repair, apoptosis and autophagy
|
Barros, E. |
|
2014 |
50 |
S5 |
p. S75- 1 p. |
artikel |
100 |
715: BCL-2 dependence in T-cell leukemia is defined by the maturation stage of the clone of origin
|
Ni Chonghaile, T. |
|
2014 |
50 |
S5 |
p. S172- 1 p. |
artikel |
101 |
241: Bcl-xL protein overexpression enhances tumor progression of human melanoma cells in zebrafish xenograft model: involvement of interleukin 8
|
Gabellini, C. |
|
2014 |
50 |
S5 |
p. S56- 1 p. |
artikel |
102 |
689: Bellini duct carcinomas have a different genetic signature compared to urothelial carcinomas of the upper urinary tract
|
Jung, V. |
|
2014 |
50 |
S5 |
p. S166- 1 p. |
artikel |
103 |
159: 11beta-hydroxysteroid dehydrogenase in human colon and colonic tumors
|
Pácha, J. |
|
2014 |
50 |
S5 |
p. S35- 1 p. |
artikel |
104 |
725: Biodegradable amphiphilic gelatin/calcium phosphate co-delivery systems with simultaneously encapsulating hydrophilic and hydrophobic drugs for enhanced tumor therapy
|
Chen, S. |
|
2014 |
50 |
S5 |
p. S174- 1 p. |
artikel |
105 |
110: Biological activity of novel platinum(II)–iodido complexes
|
Filipovic, L. |
|
2014 |
50 |
S5 |
p. S25- 1 p. |
artikel |
106 |
49: Blocking the PD-1/PD-L1 axis for cancer therapy
|
Drake, C. |
|
2014 |
50 |
S5 |
p. S12-S13 2 p. |
artikel |
107 |
362: BMP4 suppresses breast cancer metastasis through down-regulation of G-CSF
|
Anderson, R.L. |
|
2014 |
50 |
S5 |
p. S86- 1 p. |
artikel |
108 |
230: BRAF V600E-mutated cells in a papillary thyroid carcinoma do not form a compact ball, but a mesh of cells sparsely embedded within the stroma
|
Antoniou, A. |
|
2014 |
50 |
S5 |
p. S53- 1 p. |
artikel |
109 |
852: Branched cell-penetrating peptide drug conjugates for overcoming drug resistance
|
Kaloyanova, S. |
|
2014 |
50 |
S5 |
p. S207-S208 2 p. |
artikel |
110 |
324: BRCA1 as a regulator of global cell metabolism – identifying functional targets through integromic analysis
|
Powell, A. |
|
2014 |
50 |
S5 |
p. S77- 1 p. |
artikel |
111 |
966: BRCA1 VUS: an approach to assess functional impact using transcription activation and PALB2 interaction
|
De Gregoris, G. |
|
2014 |
50 |
S5 |
p. S236- 1 p. |
artikel |
112 |
313: Breast cancer stem cells are more resistant than parental cells to a novel palladium (II) saccharinate complex
|
Karakas, D. |
|
2014 |
50 |
S5 |
p. S74-S75 2 p. |
artikel |
113 |
144: Breast cancer tumor secreted factors induce both endothelial activation and increment of vascular permeability in vitro
|
Gallardo Vera, M.A. |
|
2014 |
50 |
S5 |
p. S32- 1 p. |
artikel |
114 |
188: Bromelain and N-acetylcysteine induce cytotoxic effects and reduce the expression of mucin in mucin-producing carcinoma cell lines of gastrointestinal origin
|
Amini, A. |
|
2014 |
50 |
S5 |
p. S43- 1 p. |
artikel |
115 |
751: Butyrate and irinotecan combination as a new therapeutic approach for colon cancer
|
Encarnação, J.C. |
|
2014 |
50 |
S5 |
p. S180- 1 p. |
artikel |
116 |
373: c-Abl antagonizes the YAP oncogenic function
|
Keshet, R. |
|
2014 |
50 |
S5 |
p. S89- 1 p. |
artikel |
117 |
374: c-Abl tyrosine kinase regulates recovery from the G2-M DNA damage induced checkpoint
|
Meltser, V. |
|
2014 |
50 |
S5 |
p. S89- 1 p. |
artikel |
118 |
635: CA IX inhibitor 4-(3′-(3″,5″-dimethylphenyl)ureido)phenyl sulfamate (S4) as an adjuvant to doxorubicin chemotherapy reduces metastatic dissemination
|
Gieling, R.G. |
|
2014 |
50 |
S5 |
p. S151- 1 p. |
artikel |
119 |
480: Calcium sensing receptor mediated downstream signalling in colonocytes
|
Tennakoon, S. |
|
2014 |
50 |
S5 |
p. S115-S116 2 p. |
artikel |
120 |
21: Cancer and ageing: Rival demons?
|
Campisi, J. |
|
2014 |
50 |
S5 |
p. S6-S7 2 p. |
artikel |
121 |
261: Cancer-associated fibroblast (CAF)-derived exosome may mediate breast cancer progression by reducing exosomal microRNAs
|
Kim, J.E. |
|
2014 |
50 |
S5 |
p. S61- 1 p. |
artikel |
122 |
5: Cancer research from the bench to the bedside
|
Wiestler, O. |
|
2014 |
50 |
S5 |
p. S2- 1 p. |
artikel |
123 |
805: Cancer stem cell-like cells mediate adaptive resistance to targeted cancer therapies
|
Jokinen, E. |
|
2014 |
50 |
S5 |
p. S194-S195 2 p. |
artikel |
124 |
376: Cancer stem cells, a fuzzy evolving concept: A cell population or a cell property?
|
Dumont, J. |
|
2014 |
50 |
S5 |
p. S90- 1 p. |
artikel |
125 |
473: Canonical Notch signalling is inactive in urothelial carcinoma
|
Koch, A. |
|
2014 |
50 |
S5 |
p. S114- 1 p. |
artikel |
126 |
739: Can photodynamic therapy make a difference in retinoblastoma? In vitro studies
|
Teixo, R. |
|
2014 |
50 |
S5 |
p. S177- 1 p. |
artikel |
127 |
740: Can photodynamic therapy make a difference in retinoblastoma? In vivo studies
|
Brites, G. |
|
2014 |
50 |
S5 |
p. S177-S178 2 p. |
artikel |
128 |
552: CDH3/P-cadherin is negatively regulated by TAp63 in a p53-dependent manner in breast cancer cells: Effects on P-cadherin-mediated invasion and self-renewal
|
Albergaria, A. |
|
2014 |
50 |
S5 |
p. S133- 1 p. |
artikel |
129 |
245: CD9 is required for stromal cell invasion of breast cancer cells
|
Rappa, G. |
|
2014 |
50 |
S5 |
p. S57- 1 p. |
artikel |
130 |
868: CD70 methylation and expression in early breast cancer
|
Petrau, C. |
|
2014 |
50 |
S5 |
p. S212- 1 p. |
artikel |
131 |
615: Cell-based biopharmaceuticals in a Phase I/II trial (TREAT-ME 1) for targeted drug- and gene delivery as an innovative treatment modality in advanced cancer
|
Huss, R. |
|
2014 |
50 |
S5 |
p. S147- 1 p. |
artikel |
132 |
885: Cell-type specific functions for the immune adapter protein MyD88 in colorectal carcinogenesis
|
Holtorf, A. |
|
2014 |
50 |
S5 |
p. S216- 1 p. |
artikel |
133 |
180: Cellular and molecular regulations of head and neck carcinogenesis under diabetic environment
|
Chang, W.J. |
|
2014 |
50 |
S5 |
p. S40-S41 2 p. |
artikel |
134 |
923: Cellular motility properties after X and proton beam irradiation
|
Jasinska, K. |
|
2014 |
50 |
S5 |
p. S226- 1 p. |
artikel |
135 |
954: Cervical cancer incidence in the Kyrgyz Republic
|
Makimbetov, E. |
|
2014 |
50 |
S5 |
p. S232-S233 2 p. |
artikel |
136 |
400: Changes in colorectal carcinoma genomes under anti-EGFR therapy identified by whole-genome plasma DNA sequencing
|
Heitzer, E. |
|
2014 |
50 |
S5 |
p. S96- 1 p. |
artikel |
137 |
900: Changes in NK cell effector function, subset distribution and receptor repertoire following in vitro NK cell and K562 tumor cell contact in melanoma patients
|
Konjevic, G. |
|
2014 |
50 |
S5 |
p. S220- 1 p. |
artikel |
138 |
877: Changes of the white blood cells subsets in HER2 positive breast cancer patients treated with trastuzumab
|
Matic, I. |
|
2014 |
50 |
S5 |
p. S214- 1 p. |
artikel |
139 |
242: Characterisation of retinoic acid effect on breast cancer cell plasticity
|
Paroni, G. |
|
2014 |
50 |
S5 |
p. S56- 1 p. |
artikel |
140 |
344: Characterisation of RNA content of cancer-derived exosomes and microvesicles
|
Line, A. |
|
2014 |
50 |
S5 |
p. S82- 1 p. |
artikel |
141 |
563: Characterising the role of Heterochromatin Protein 1 gamma in normal intestinal homeostasis and tumourigenesis
|
Lio, K. |
|
2014 |
50 |
S5 |
p. S135- 1 p. |
artikel |
142 |
176: Characterization and analysis of deregulation of signaling pathways of cancer stem cells derived from oral squamous cell carcinoma
|
Andrade, N. |
|
2014 |
50 |
S5 |
p. S39-S40 2 p. |
artikel |
143 |
965: Characterization of breast cancer (BC) predisposition variants in high risk BRCA1- and BRCA2-negative BC patients using panel next-gen sequencing
|
Lhota, F. |
|
2014 |
50 |
S5 |
p. S235-S236 2 p. |
artikel |
144 |
380: Characterization of CpG islands and methylation status of Claspin gene (CLSPN) promoter
|
Azenha, D. |
|
2014 |
50 |
S5 |
p. S90-S91 2 p. |
artikel |
145 |
189: Characterization of ovarian carcinoma-associated fibroblasts: The capability in predicting tumor aggressiveness
|
Liu, C. |
|
2014 |
50 |
S5 |
p. S43- 1 p. |
artikel |
146 |
485: Characterization of the Src-regulated kinome in breast cancer by chemical proteomics and functional genomics
|
Zhang, L. |
|
2014 |
50 |
S5 |
p. S116-S117 2 p. |
artikel |
147 |
820: Chemo-resistant gastric cancer: changes in Notch signalling
|
Bauer, L. |
|
2014 |
50 |
S5 |
p. S198-S199 2 p. |
artikel |
148 |
318: Chemosensitivity differs between CETCs and spheroids grown from the CETCs in cancer patients with solid tumors
|
Pizon, M. |
|
2014 |
50 |
S5 |
p. S76- 1 p. |
artikel |
149 |
863: Chemosensitization and radiosensitization effects of glioblastoma cells by the histone deacetylase inhibitor, givinostat (ITF2357) in glioblastoma cell models
|
Gravina, G.L. |
|
2014 |
50 |
S5 |
p. S211- 1 p. |
artikel |
150 |
834: Chemotherapeutic-loaded biodegradable nanoparticles in the treatment of chronic lymphocytic leukemia
|
Capolla, S. |
|
2014 |
50 |
S5 |
p. S202- 1 p. |
artikel |
151 |
306: Chemotherapy sensitizes p95HER2-positive breast cancers to trastuzumab
|
Morancho, B. |
|
2014 |
50 |
S5 |
p. S72-S73 2 p. |
artikel |
152 |
607: Chick embryo chorioallantoic membrane model for testing novel anticancer substances
|
Zabielska, K. |
|
2014 |
50 |
S5 |
p. S146- 1 p. |
artikel |
153 |
742: Chiral 6,7-bis(hydroxymethyl)-1H,3H-pyrrolo[1,2-c]thiazoles as anticancer agents against breast cancer MCF7 and HCC1806 cell lines
|
Santos, K. |
|
2014 |
50 |
S5 |
p. S178- 1 p. |
artikel |
154 |
7: Chromatin dynamics and cell cycle: From histone variants to heterochromatin
|
Almouzni, G. |
|
2014 |
50 |
S5 |
p. S3- 1 p. |
artikel |
155 |
401: Chromatin remodelling by the p400 ATPase influences DNA double-strand breaks repair and genetic instability independently of the H2AZ histone variant incorporation
|
Canitrot, Y. |
|
2014 |
50 |
S5 |
p. S96- 1 p. |
artikel |
156 |
569: Chronic and low doses exposure of environmental pollutants induces phenotypic alterations in a tumour progression model of breast cancer
|
Donini, C.F. |
|
2014 |
50 |
S5 |
p. S136-S137 2 p. |
artikel |
157 |
222: Chronic intermittent hypoxia triggers adaptive changes that promote protection against cell death
|
Matschke, J. |
|
2014 |
50 |
S5 |
p. S51- 1 p. |
artikel |
158 |
889: Circulating dendritic cells are gut homing in colorectal cancers - A role in diagnosis and prognosis in colorectal cancer?
|
Lee, G. |
|
2014 |
50 |
S5 |
p. S217- 1 p. |
artikel |
159 |
977: Circulating free DNA: a ‘liquid biopsy’ for the early detection of cancer?
|
Trigg, R.M. |
|
2014 |
50 |
S5 |
p. S238- 1 p. |
artikel |
160 |
738: Circulating miRNAs associated with progression of colorectal cancer
|
Aherne, S. |
|
2014 |
50 |
S5 |
p. S177- 1 p. |
artikel |
161 |
601: Cisplatin response in a panel of patient-derived ovarian carcinoma xenografts: roles of epithelial mesenchymal transition and DNA repair
|
Ricci, F. |
|
2014 |
50 |
S5 |
p. S145- 1 p. |
artikel |
162 |
447: Classification of human cutaneous metastatic melanoma cell lines and clinical samples by receptor tyrosine kinases- and phenotype-driven gene expression signatures
|
Dugo, M. |
|
2014 |
50 |
S5 |
p. S108- 1 p. |
artikel |
163 |
471: Class-I histone deacetylases are deregulated in urothelial cancer but may differ in suitability as therapeutic targets
|
Lehmann, M. |
|
2014 |
50 |
S5 |
p. S114- 1 p. |
artikel |
164 |
421: Class-I histone deacetylases are deregulated in urothelial cancer but may differ in suitability as therapeutic targets
|
Lehmann, M. |
|
2014 |
50 |
S5 |
p. S101- 1 p. |
artikel |
165 |
182: Class III beta-tubulin is a target gene of HIF-2alpha in glioblastoma cells exposed to hypoxia
|
Bordji, K. |
|
2014 |
50 |
S5 |
p. S41- 1 p. |
artikel |
166 |
915: Claudin-3 overexpression confers radioresistance of colorectal cancer cells
|
Fortunato-Miranda, N. |
|
2014 |
50 |
S5 |
p. S224- 1 p. |
artikel |
167 |
744: Clinical and histopathological characteristics of HER2-positive breast cancer in patients treated with adjuvant trastuzumab
|
Jurcic, P. |
|
2014 |
50 |
S5 |
p. S179- 1 p. |
artikel |
168 |
233: Clinical and prognostic values of the pretreatment PSA doubling time in patients with prostate cancer
|
Bogomolov, O. |
|
2014 |
50 |
S5 |
p. S54- 1 p. |
artikel |
169 |
710: Clinical implication of UGT1A1 promoter polymorphism for irinotecan dose escalation in metastatic colorectal cancer patients treated with bevacizumab combined with FOLFIRI in the first-line setting
|
Wang, J. |
|
2014 |
50 |
S5 |
p. S171- 1 p. |
artikel |
170 |
638: Clinical relevance of telomere length and telomerase activity in colorectal cancer
|
De Juan Chocano, C. |
|
2014 |
50 |
S5 |
p. S152- 1 p. |
artikel |
171 |
469: CLIP2 as radiation biomarker in papillary thyroid carcinoma
|
Selmansberger, M. |
|
2014 |
50 |
S5 |
p. S113- 1 p. |
artikel |
172 |
309: Clonal succession of transiently active TIC clones in human pancreatic cancer
|
Ball, C.R. |
|
2014 |
50 |
S5 |
p. S73- 1 p. |
artikel |
173 |
642: 11C-MET-PET for monitoring of early treatment response in multiple myeloma
|
Lückerath, K. |
|
2014 |
50 |
S5 |
p. S153- 1 p. |
artikel |
174 |
211: Co-evolution of stroma and neoplastic cells in prostate cancer is sustained by reprogramming energy metabolism
|
Bologna, M. |
|
2014 |
50 |
S5 |
p. S48- 1 p. |
artikel |
175 |
897: Co-expression of chimeric antigen receptor (CAR) and miRNAs to T cell therapy
|
Carneiro, M. |
|
2014 |
50 |
S5 |
p. S219- 1 p. |
artikel |
176 |
841: Colorectal cancer cells with acquired resistance to anti-EGFR mAb ICR62 remain highly sensitive to treatment with small molecule tyrosine kinase inhibitors
|
Khelwatty, S. |
|
2014 |
50 |
S5 |
p. S204-S205 2 p. |
artikel |
177 |
789: Combinatorial treatment of lung cancer cell lines and their spheroids-cancer stem cells with standard therapeutic drug and salinomycin
|
Xiao, Z. |
|
2014 |
50 |
S5 |
p. S190- 1 p. |
artikel |
178 |
444: Combined microRNA and ER expression: a new classifier for familial and sporadic breast cancer patients
|
De Summa, S. |
|
2014 |
50 |
S5 |
p. S107- 1 p. |
artikel |
179 |
807: Combined treatment of pancreatic tumour cells with bioactive food components reduces tumour growth and potentiates gemcitabine toxicity in a preclinical mouse model
|
Dabernat, S. |
|
2014 |
50 |
S5 |
p. S195- 1 p. |
artikel |
180 |
403: Comparative evaluation of EGFR mutation testing of tissue and cytology using direct sequencing, pyrosequencing and peptide nucleic acid clamping in lung adenocarcinoma
|
Kim, W. |
|
2014 |
50 |
S5 |
p. S96- 1 p. |
artikel |
181 |
932: Comparative global characterisation of microRNA-expression in radiation-associated and sporadic breast carcinomas
|
Wilke, C. |
|
2014 |
50 |
S5 |
p. S229- 1 p. |
artikel |
182 |
924: Comparative study of chondrosarcomas response to DNA damage: Impact of HIF2 expression
|
Lhuissier, E. |
|
2014 |
50 |
S5 |
p. S226- 1 p. |
artikel |
183 |
653: Comparison of direct sequencing and peptide nucleic acid clamping of EGFR gene in patients with non-small cell lung cancer
|
Kim, Y. |
|
2014 |
50 |
S5 |
p. S156- 1 p. |
artikel |
184 |
268: Comparison of membrane fatty acid compositions of mesenchymal stem cells and mature mesenchymal cell lines using GC-FID method
|
Ozgurtas, T. |
|
2014 |
50 |
S5 |
p. S63- 1 p. |
artikel |
185 |
432: Comparison of two library construction strategies for targeted resequencing of BRCA1/2 genes in Bulgarian breast cancer patients on NGS platform
|
Dacheva, D. |
|
2014 |
50 |
S5 |
p. S103-S104 2 p. |
artikel |
186 |
679: Comprehensive meta-analysis of publicly available microarray data in head and neck cancer
|
De Cecco, L. |
|
2014 |
50 |
S5 |
p. S163- 1 p. |
artikel |
187 |
438: Comprehensive mutational landscape of human stable colorectal tumors in stage II
|
Sanz-Pamplona, R. |
|
2014 |
50 |
S5 |
p. S105-S106 2 p. |
artikel |
188 |
806: Concentration dependent effect of sesamol on cell cycle arrest
|
Weerapreeyakul, N. |
|
2014 |
50 |
S5 |
p. S195- 1 p. |
artikel |
189 |
700: Confocal fluorescence endomicroscopy in vivo for the detection of tumour microenvironment and healthy tissue margin
|
Johnson, S.P. |
|
2014 |
50 |
S5 |
p. S168-S169 2 p. |
artikel |
190 |
Congress Committees
|
|
|
2014 |
50 |
S5 |
p. vii- 1 p. |
artikel |
191 |
407: Constitutional and somatic rearrangement of chromosome 21 in acute lymphoblastic leukaemia
|
Li, Y. |
|
2014 |
50 |
S5 |
p. S97- 1 p. |
artikel |
192 |
528: Cooperation between Rho-ROCK and STAT 3 signaling modulates colon cancer cell proliferation
|
Peres-Moreira, R. |
|
2014 |
50 |
S5 |
p. S127- 1 p. |
artikel |
193 |
392: Copy number alterations in lung cancer
|
Dalay, N. |
|
2014 |
50 |
S5 |
p. S93- 1 p. |
artikel |
194 |
460: COSMIC: Exploring novel cancer biomarkers
|
Forbes, S. |
|
2014 |
50 |
S5 |
p. S111- 1 p. |
artikel |
195 |
178: COX-2 independent induction of apoptosis by two synthetic COX-2 inhibitors in breast cancer cell line
|
Salimi, M. |
|
2014 |
50 |
S5 |
p. S40- 1 p. |
artikel |
196 |
277: COX-2/PGE2 promotes lung cancer invasion/metastasis via MIG-7 and phosphorylated prohibitin
|
Liang, S.M. |
|
2014 |
50 |
S5 |
p. S65- 1 p. |
artikel |
197 |
578: Critical age windows of radiation exposure for cancer risk in experimental animal models
|
Shimada, Y. |
|
2014 |
50 |
S5 |
p. S139- 1 p. |
artikel |
198 |
794: Crizotinib is an allosteric ABL-inhibitor targeting both native BCR/ABL and BCR/ABL-T315I in vitro and in vivo models of PH+ leukemia
|
Mahajna, J. |
|
2014 |
50 |
S5 |
p. S191-S192 2 p. |
artikel |
199 |
879: Cryotherapy enhances the antigen-specific T cell immune responses and therapeutic antitumor effects generated by therapeutic HPV DNA vaccine
|
Lee, S.Y. |
|
2014 |
50 |
S5 |
p. S214-S215 2 p. |
artikel |
200 |
59: CTCs and cfDNA, will they be useful for early detection of cancer?
|
Dive, C. |
|
2014 |
50 |
S5 |
p. S15- 1 p. |
artikel |
201 |
665: Cullin-RING ligases inhibition is a potential new therapeutic strategy in soft tissue sarcomas
|
Martín, A. |
|
2014 |
50 |
S5 |
p. S159- 1 p. |
artikel |
202 |
762: Curcumin induces the apoptosis of human monocytic leukemia THP-1 cells via the activation of JNK/ERK Pathways
|
Yang, W. |
|
2014 |
50 |
S5 |
p. S183- 1 p. |
artikel |
203 |
688: CXCL12/CXCR4 ratio in colorectal cancer patients
|
Stanisavljevic, L. |
|
2014 |
50 |
S5 |
p. S165-S166 2 p. |
artikel |
204 |
864: CXCR4 inhibition reduces bone metastases by affecting tumour growth and tumorigenic potential in prostate cancer preclinical models
|
Gravina, G.L. |
|
2014 |
50 |
S5 |
p. S211- 1 p. |
artikel |
205 |
171: Cycling hypoxia amplifies tumor microenvironment inflammation
|
Michiels, C. |
|
2014 |
50 |
S5 |
p. S38- 1 p. |
artikel |
206 |
292: Cytotoxic effect and apoptosis induction by phytohemagglutinin erythroagglutinating on lung cancer cells
|
Chen, K.Y. |
|
2014 |
50 |
S5 |
p. S69- 1 p. |
artikel |
207 |
891: Cytotoxic T lymphocytes functionally active against tumor microenvironment-derived specific antigen
|
Bojin, M. |
|
2014 |
50 |
S5 |
p. S217-S218 2 p. |
artikel |
208 |
895: Dasatinib-induced reduction of tumor growth is accompanied by the changes in the immune profile in melanoma B16.OVA mouse model
|
Ilander, M. |
|
2014 |
50 |
S5 |
p. S219- 1 p. |
artikel |
209 |
639: DAXX/ATRX loss and chromosomal instability in pancreatic neuroendocrine tumors (pNETs)
|
Marinoni, I. |
|
2014 |
50 |
S5 |
p. S152- 1 p. |
artikel |
210 |
823: 3-deazaneplanocin A (DZNep), an inhibitor of histone methyltransferase EZH2, induces apoptosis and reduces cell migration in chondrosarcoma cells
|
Girard, N. |
|
2014 |
50 |
S5 |
p. S199- 1 p. |
artikel |
211 |
343: Deciphering the role of ubiquitin specific peptidase 15 (USP15) in human glioblastoma
|
Oikonomaki, M. |
|
2014 |
50 |
S5 |
p. S82- 1 p. |
artikel |
212 |
938: Deleterious RAD51C germ line mutations rarely predispose to breast and ovarian cancer in Pakistan
|
Rashid, M. |
|
2014 |
50 |
S5 |
p. S229-S230 2 p. |
artikel |
213 |
399: Dependence of malignancy grade of gastrointestinal stromal tumor from a genetic profile
|
Gagarin, I. |
|
2014 |
50 |
S5 |
p. S95- 1 p. |
artikel |
214 |
881: Depletion of tumor-associated macrophages enhances peptide-based cancer immunotherapy
|
Liu, S. |
|
2014 |
50 |
S5 |
p. S215- 1 p. |
artikel |
215 |
598: Design, synthesis and evaluation of COX-2 PET imaging probes
|
Pacelli, A. |
|
2014 |
50 |
S5 |
p. S144- 1 p. |
artikel |
216 |
428: Detecting and quantifying low level variants in Sanger sequencing traces
|
Schreiber, E. |
|
2014 |
50 |
S5 |
p. S103- 1 p. |
artikel |
217 |
604: Detection of hot spot and pathway related variants in chronic lymphocytic leukemia by multiplexed amplicon sequencing
|
Vollbrecht, C. |
|
2014 |
50 |
S5 |
p. S145- 1 p. |
artikel |
218 |
492: Development of a 3D culture system to study the deterioration of oral cancer
|
Chang, S.J. |
|
2014 |
50 |
S5 |
p. S118- 1 p. |
artikel |
219 |
839: Development of a novel anti-angiogenic therapy based on multi-target destabilization of short-lived mRNAs
|
Rataj, F. |
|
2014 |
50 |
S5 |
p. S204- 1 p. |
artikel |
220 |
853: Development of a novel tumor homing compound targeting glioblastoma cells
|
Giannopoulou, E. |
|
2014 |
50 |
S5 |
p. S208- 1 p. |
artikel |
221 |
813: Development of self-assembling lecithin-based polymeric mixed micellar systems for quercetin in cancer treatment
|
Chen, Y.C. |
|
2014 |
50 |
S5 |
p. S197- 1 p. |
artikel |
222 |
840: Development of substrate-based radiotracers for imaging of tumour-associated lysyl oxidase activity by positron emission tomography
|
Kuchar, M. |
|
2014 |
50 |
S5 |
p. S204- 1 p. |
artikel |
223 |
1: Development of targeted cancer therapies
|
Ullrich, A. |
|
2014 |
50 |
S5 |
p. S1- 1 p. |
artikel |
224 |
131: Diacylglycerol kinase alpha regulates Src and promotes 3D growth in breast cancer
|
Torres-Ayuso, P. |
|
2014 |
50 |
S5 |
p. S29- 1 p. |
artikel |
225 |
590: Dickkopf-3 (DKK3), biomarker in head and neck cancer and its implication in tumor progression
|
Cisa, S. |
|
2014 |
50 |
S5 |
p. S142- 1 p. |
artikel |
226 |
584: Dietary lipids may modulate the xenobiotic metabolism in a chemically-induced breast cancer model
|
Manzanares, M.A. |
|
2014 |
50 |
S5 |
p. S140-S141 2 p. |
artikel |
227 |
582: Dietary lipids modify the composition of tumour cell membrane microdomains in experimental mammary cancer
|
Solanas, M. |
|
2014 |
50 |
S5 |
p. S140- 1 p. |
artikel |
228 |
896: Differentially expressed functions and genes between serrated adenocarcinoma and sporadic colorectal carcinoma showing histological and molecular features of high level of microsatellite instability
|
Turpín Sevilla, M. |
|
2014 |
50 |
S5 |
p. S219- 1 p. |
artikel |
229 |
547: Different micro-RNA expression profiles distinguish subtypes of neuroendocrine tumours of the lung: results of a profiling study
|
Mairinger, F. |
|
2014 |
50 |
S5 |
p. S132- 1 p. |
artikel |
230 |
283: Disruption of cortical tension patterning drives the outgrowth of oncogenic cells
|
Wu, S. |
|
2014 |
50 |
S5 |
p. S67- 1 p. |
artikel |
231 |
753: Disulfiram-induced cytotoxicity and endolysosomal sequestration of zinc in breast cancer cell models
|
Wiggins, H. |
|
2014 |
50 |
S5 |
p. S181- 1 p. |
artikel |
232 |
457: Diversity of methylation patterns in HPV16 LCR in cervical cancer
|
Amaro-Filho, S. |
|
2014 |
50 |
S5 |
p. S110-S111 2 p. |
artikel |
233 |
920: DNA damage and oxidative stress after low doses of X and proton beam irradiation
|
Jasinska, K. |
|
2014 |
50 |
S5 |
p. S225- 1 p. |
artikel |
234 |
378: DNA2 is highly mutated in estrogen-dependent cancers; from a bioinformatics screen to the effect of clinical mutations on cellular growth
|
Strauss, C. |
|
2014 |
50 |
S5 |
p. S90- 1 p. |
artikel |
235 |
412: DNA methylation levels of OPCML and SFRP1 as diagnostic biomarkers in cholangiocarcinoma
|
Limpaiboon, T. |
|
2014 |
50 |
S5 |
p. S98- 1 p. |
artikel |
236 |
416: DNA methylation profiles in invasive breast tumours associate with methylation in lymph node metastases and not in plasma samples
|
Fridrichova, I. |
|
2014 |
50 |
S5 |
p. S99- 1 p. |
artikel |
237 |
728: DNA-PKcs inhibition enhances response to DNA damaging agents and is associated with Rad51 downregulation
|
Sousa, C. |
|
2014 |
50 |
S5 |
p. S175- 1 p. |
artikel |
238 |
772: Docosahexaenoic acid may indirectly increase proteasome activity through reactive oxygen species in human cervical cancer HeLa cells
|
Lim, K. |
|
2014 |
50 |
S5 |
p. S185- 1 p. |
artikel |
239 |
884: Do serum components play a role in the elimination of mitochondria from necrotic cells by phagocytes?
|
Hessenberger, A. |
|
2014 |
50 |
S5 |
p. S216- 1 p. |
artikel |
240 |
956: Double heterozygotes among breast cancer patients analyzed for BRCA1, CHEK2, ATM, NBN/NBS1, and BLM germ-line mutations
|
Sokolenko, A. |
|
2014 |
50 |
S5 |
p. S233- 1 p. |
artikel |
241 |
391: Downregulation of the DLEC1 gene is not associated with promoter methylation in head and neck cancer
|
Buyru, N. |
|
2014 |
50 |
S5 |
p. S93- 1 p. |
artikel |
242 |
909: Drug delivery evaluation with cell viability: A potential misinterpretation
|
Tseng, H. |
|
2014 |
50 |
S5 |
p. S222- 1 p. |
artikel |
243 |
802: Drug delivery systems (DDS) for anticancer drugs originated from medicinal plant
|
Siwe Noundou, X. |
|
2014 |
50 |
S5 |
p. S194- 1 p. |
artikel |
244 |
726: Drug resistance acquisition is associated to expression changes in caspases and Bcl-2 proteins in a human lymphoblastic cell line
|
Cerezo Fernández, D. |
|
2014 |
50 |
S5 |
p. S174- 1 p. |
artikel |
245 |
57: Early detection biomarkers for oesophageal cancer
|
Fitzgerald, R. |
|
2014 |
50 |
S5 |
p. S14- 1 p. |
artikel |
246 |
882: Early development of CD49d-high Th1 memory phenotype CD4+T cells in the murine peritoneal cavity
|
Bae, Y. |
|
2014 |
50 |
S5 |
p. S215- 1 p. |
artikel |
247 |
929: Early NFKB signalling pathway activation in Ramos B cells in response to ionizing radiation
|
Di Nisio, C. |
|
2014 |
50 |
S5 |
p. S228- 1 p. |
artikel |
248 |
336: EDI3, a glycerophosphodiesterase linking metabolism to cellular migration and attachment
|
Marchan, R. |
|
2014 |
50 |
S5 |
p. S80- 1 p. |
artikel |
249 |
Editorial Board
|
|
|
2014 |
50 |
S5 |
p. i-iv nvt p. |
artikel |
250 |
793: Effective inhibition of glioblastoma growth with dacomitinib: an irreversible EGFR inhibitor
|
Zahonero, C. |
|
2014 |
50 |
S5 |
p. S191- 1 p. |
artikel |
251 |
960: Effect of asthma on cancer incidence and survival: A population based study in Sweden
|
Ji, J. |
|
2014 |
50 |
S5 |
p. S234- 1 p. |
artikel |
252 |
288: Effect of boric acid on head and neck cancer cell lines
|
Gunduz, M. |
|
2014 |
50 |
S5 |
p. S68- 1 p. |
artikel |
253 |
224: Effect of HuIFN-α and Royal jelly on the proliferation of human colon cancer (CaCo-2) cells in vitro
|
Rihar, K. |
|
2014 |
50 |
S5 |
p. S51-S52 2 p. |
artikel |
254 |
930: Effect of radiotherapy on macrophages
|
Pinto, A.T. |
|
2014 |
50 |
S5 |
p. S228- 1 p. |
artikel |
255 |
210: Effect of sesamin, sesamolin and sesamol on P-glycoprotein mediated efflux
|
Junhom, C. |
|
2014 |
50 |
S5 |
p. S48- 1 p. |
artikel |
256 |
356: Effect of SNAIL1 expression on the epithelial–mesenchymal transition in prostate cancer
|
Contreras, H. |
|
2014 |
50 |
S5 |
p. S85- 1 p. |
artikel |
257 |
692: Effect of specific PI3K/mTOR inhibitors in squamous lung cancer cells carrying PI3K alterations
|
Bonelli, M. |
|
2014 |
50 |
S5 |
p. S166-S167 2 p. |
artikel |
258 |
958: Effect of Survivin gene −1547 A>G (rs3764383) polymorphism in Turkish breast cancer patients
|
Acar, M. |
|
2014 |
50 |
S5 |
p. S233-S234 2 p. |
artikel |
259 |
355: Effects of anti-proliferative lichen metabolite, protolichesterinic acid on fatty acid synthase and lipid composition in breast cancer cells
|
Bessadottir, M. |
|
2014 |
50 |
S5 |
p. S85- 1 p. |
artikel |
260 |
656: Effects of chemotherapy of small cell lung cancer on pH-regulating proteins
|
Klameth, L. |
|
2014 |
50 |
S5 |
p. S157- 1 p. |
artikel |
261 |
383: Effects of different additives for detection of single nucleotide polymorphisms in promoter sequence EGFR gene in NSCLC
|
Jurisic, V. |
|
2014 |
50 |
S5 |
p. S91- 1 p. |
artikel |
262 |
908: Effects of ionizing radiation on H69 cell line
|
Mendes, F. |
|
2014 |
50 |
S5 |
p. S222- 1 p. |
artikel |
263 |
860: Effects of novel anticancer tambjamine analogs on lung cancer cell lines and human lung primary cultures
|
Manuel-Manresa, P. |
|
2014 |
50 |
S5 |
p. S210- 1 p. |
artikel |
264 |
198: Effects of pro-apoptotic Bcl-2 on morin-induced apoptosis in human leukemia U937 cells
|
Park, C. |
|
2014 |
50 |
S5 |
p. S45- 1 p. |
artikel |
265 |
439: Effects of the histone deacetylase inhibitor romidepsin in lymphoma B-cells and BCL6 regulation
|
Cortiguera, M.G. |
|
2014 |
50 |
S5 |
p. S106- 1 p. |
artikel |
266 |
246: Effects of the potential energy restriction mimetic agent delta2-troglitazone in breast cancer cells
|
Grillier-Vuissoz, I. |
|
2014 |
50 |
S5 |
p. S57-S58 2 p. |
artikel |
267 |
623: Efficacy of temsirolimus for advanced hepatocellular carcinoma (HCC) - assessment of pS6 as potential prognostic biomarker of response
|
Yeo, W. |
|
2014 |
50 |
S5 |
p. S148- 1 p. |
artikel |
268 |
130: Eight microRNAs as biomarkers for metastatic spread in triple negative breast cancer
|
Mathe, A. |
|
2014 |
50 |
S5 |
p. S29- 1 p. |
artikel |
269 |
315: Elovl6 overexpression promotes liver carcinogenesis
|
Shiau, A.L. |
|
2014 |
50 |
S5 |
p. S75- 1 p. |
artikel |
270 |
367: Elucidating the synthetic lethal effect of CDK inhibition in triple negative breast cancer
|
Rohrberg, J. |
|
2014 |
50 |
S5 |
p. S88- 1 p. |
artikel |
271 |
760: Enhanced antitumor effects of oncolytic reovirus and trastuzumab combination therapy in human HER2-positive gastric cancer
|
Kataoka, H. |
|
2014 |
50 |
S5 |
p. S183- 1 p. |
artikel |
272 |
797: Enhancement of the cytotoxic effect of doxorubicin through gap junctional intercellular communication in esophageal cancer cells
|
Tanaka, T. |
|
2014 |
50 |
S5 |
p. S192- 1 p. |
artikel |
273 |
453: Enhancer of Zeste Homolog 2 (EZH2) modulation in either embryonal or PAX3-FOXO1 alveolar rhabdomyosarcoma shows different anti-tumoral effects
|
Rota, R. |
|
2014 |
50 |
S5 |
p. S109-S110 2 p. |
artikel |
274 |
266: EphB4 negatively regulates blood vessel network formation and perfusion in human A375 melanoma xenografts
|
Neuber, C. |
|
2014 |
50 |
S5 |
p. S62-S63 2 p. |
artikel |
275 |
972: Epidemiology of oral and pharyngeal cancer at the National Cancer Institute, Cairo Egypt
|
Labib, N. |
|
2014 |
50 |
S5 |
p. S237-S238 2 p. |
artikel |
276 |
451: Epigenetic changes and dietary factors in human and experimental breast cancer
|
Escrich, E. |
|
2014 |
50 |
S5 |
p. S109- 1 p. |
artikel |
277 |
395: Epigenetic deregulation of HOXA genes associated with aberrant expression in glioblastoma
|
Kurscheid, S. |
|
2014 |
50 |
S5 |
p. S94- 1 p. |
artikel |
278 |
423: Epigenetic effects of radiation on hTERT-immortalized mesenchymal stem cells
|
Orun, O. |
|
2014 |
50 |
S5 |
p. S101- 1 p. |
artikel |
279 |
971: Epigenetic gender differences in colorectal cancer
|
Toth, R. |
|
2014 |
50 |
S5 |
p. S237- 1 p. |
artikel |
280 |
573: Epigenetic inactivation of miR-9 family microRNAs in chronic lymphocytic leukemia − implications on constitutive activation of NF-κB pathway
|
Wang, L.Q. |
|
2014 |
50 |
S5 |
p. S138- 1 p. |
artikel |
281 |
411: Epigenetic mechanisms of cadmium urothelial carcinogenesis
|
Cowling, L. |
|
2014 |
50 |
S5 |
p. S98- 1 p. |
artikel |
282 |
414: Epigenetic modifications of androgen receptor signaling in castration resistant prostate cancer (CRPC)
|
Saraç, H. |
|
2014 |
50 |
S5 |
p. S99- 1 p. |
artikel |
283 |
464: Epigenetic pattern analysis for sub-classification of cancer and immune cell infiltration
|
Loewe, R.P. |
|
2014 |
50 |
S5 |
p. S112- 1 p. |
artikel |
284 |
436: Epigenetic regulation of AREG and EREG expression by ZBTB33/KAISO in colorectal cancer
|
Ispasanie, S. |
|
2014 |
50 |
S5 |
p. S105- 1 p. |
artikel |
285 |
572: Epigenetic silencing of tumor suppressor miR-3151 in Chinese chronic lymphocytic leukemia patients
|
Wang, L.Q. |
|
2014 |
50 |
S5 |
p. S137- 1 p. |
artikel |
286 |
18: Epigenetics of cellular senescence, insights into cancer and aging
|
Adams, P. |
|
2014 |
50 |
S5 |
p. S6- 1 p. |
artikel |
287 |
4: Epigenetic targets in cancer
|
Helin, K. |
|
2014 |
50 |
S5 |
p. S1- 1 p. |
artikel |
288 |
368: ErbB3 in the nucleus – mechanisms of nuclear entry
|
Reif, R. |
|
2014 |
50 |
S5 |
p. S88- 1 p. |
artikel |
289 |
371: Esophageal squamous cell carcinoma cells stimulate the formation of a hyaluronan-rich microenvironment: implications for fibroblast phenotype and sensitivity to tyrosine kinase inhibitors
|
Kretschmer, I. |
|
2014 |
50 |
S5 |
p. S89- 1 p. |
artikel |
290 |
398: Evaluation of microRNA expression profiles in triple-negative (ER, PR and Her2/neu) breast cancer patients with and without germ-line BRCA mutations
|
Erturk, E. |
|
2014 |
50 |
S5 |
p. S95- 1 p. |
artikel |
291 |
284: Evidence of a correlation between bcl-2 protein and miR-211 expression in melanoma cell lines
|
De Luca, T. |
|
2014 |
50 |
S5 |
p. S67- 1 p. |
artikel |
292 |
290: Examination of role of ING1 splicing variant (p33ING1) in carcinogenesis and metastasis of head and neck carcinomas
|
Gunduz, E. |
|
2014 |
50 |
S5 |
p. S68-S69 2 p. |
artikel |
293 |
Exhibitor Profiles
|
|
|
2014 |
50 |
S5 |
p. xxiv-xxviii nvt p. |
artikel |
294 |
654: Exome sequencing of normal DNA from young non-smokers with lung cancer
|
Iyevleva, A.G. |
|
2014 |
50 |
S5 |
p. S156- 1 p. |
artikel |
295 |
754: Experimental topical photodynamic therapy of various carcinomas
|
Vetvicka, D. |
|
2014 |
50 |
S5 |
p. S181- 1 p. |
artikel |
296 |
147: Exploring the metabolic profile of colorectal cancer cells from different origin
|
Abrantes, A. |
|
2014 |
50 |
S5 |
p. S33- 1 p. |
artikel |
297 |
326: Expression analyses of long non-coding RNAs in breast cancer
|
Knutsen, E. |
|
2014 |
50 |
S5 |
p. S77-S78 2 p. |
artikel |
298 |
321: Expression and cytogenetic profile of intratumor morphological heterogeneity in breast cancer
|
Denisov, E. |
|
2014 |
50 |
S5 |
p. S76-S77 2 p. |
artikel |
299 |
629: Expression and role of the embryonic protein SOX2 in head and neck squamous cell carcinoma
|
Schröck, A. |
|
2014 |
50 |
S5 |
p. S150- 1 p. |
artikel |
300 |
887: Expression and turnover of proteins govern their sampling for HLA class I presentation
|
Bassani-Sternberg, M. |
|
2014 |
50 |
S5 |
p. S216-S217 2 p. |
artikel |
301 |
565: Expression of annexin A2 controls cell motility in renal cell carcinoma
|
Cheng, C.W. |
|
2014 |
50 |
S5 |
p. S135- 1 p. |
artikel |
302 |
788: Expression of Annexin A4 regulates cisplatin-susceptibility in malignant mesothelioma
|
Nagano, K. |
|
2014 |
50 |
S5 |
p. S190- 1 p. |
artikel |
303 |
286: Expression of markers of epithelial–mesenchymal transition E-cadherin and vimentin in different immunohistochemical subtypes of breast cancer
|
Zasadkevich, Y.M. |
|
2014 |
50 |
S5 |
p. S68- 1 p. |
artikel |
304 |
253: Expression of TRF2 and its prognostic relevance in advanced stage cervical cancer patients
|
Orun, O. |
|
2014 |
50 |
S5 |
p. S59-S60 2 p. |
artikel |
305 |
113: Expression of voltage-gated sodium channel beta1 subunits in breast cancer: Promotion of tumor growth and metastasis
|
Nelson, M. |
|
2014 |
50 |
S5 |
p. S25-S26 2 p. |
artikel |
306 |
664: Expression of w3-desaturase gene inhibits tumorigenicity and metastasis of prostate cancer cells
|
Lim, K. |
|
2014 |
50 |
S5 |
p. S159- 1 p. |
artikel |
307 |
319: Expression profile of fibroblasts from tumor bearing prostate exhibits significant differences compared to BPH-derived fibroblasts
|
Jung, V. |
|
2014 |
50 |
S5 |
p. S76- 1 p. |
artikel |
308 |
442: Expression profiling of microRNAs in neuroblastoma tumors in different stages and histology
|
Ergin, K. |
|
2014 |
50 |
S5 |
p. S106-S107 2 p. |
artikel |
309 |
910: External beam radiotherapy synergizes rhenium 188-liposome against human esophageal cancer xenograft and modulates rhenium 188-liposome pharmacokinetics
|
Chen, Y.J. |
|
2014 |
50 |
S5 |
p. S222-S223 2 p. |
artikel |
310 |
827: Ex vivo combinatorial screen to identify drug sensitivity and rational treatment of chronic lymphocytic leukemia
|
Lukas, M. |
|
2014 |
50 |
S5 |
p. S200- 1 p. |
artikel |
311 |
683: Ex vivo modelling of Kras-driven murine non-small cell lung cancer
|
Närhi, K. |
|
2014 |
50 |
S5 |
p. S164- 1 p. |
artikel |
312 |
933: FancA overexpression confers radioresistance to cells of head and neck squamous cell carcinoma
|
Gimenez-Aznar, I. |
|
2014 |
50 |
S5 |
p. S229- 1 p. |
artikel |
313 |
347: Fibroblast crosstalk with anti-Her2 therapies breast cancer resistant clones
|
Fernandez, P. |
|
2014 |
50 |
S5 |
p. S82-S83 2 p. |
artikel |
314 |
509: Fibroblast growth factor receptor 1 controls cancer cell survival via ERK signaling
|
Ling, L. |
|
2014 |
50 |
S5 |
p. S123- 1 p. |
artikel |
315 |
519: Fibroblasts isolated from the cancer resistant blind mole rat Spalax exert an extraordinary anticancer activity towards human cancer cells by triggering mitochondrial-dependent apoptosis
|
Manov, I. |
|
2014 |
50 |
S5 |
p. S125- 1 p. |
artikel |
316 |
759: Ficus carica latex inhibits GBM cell proliferation by modulating let-7d expression
|
Tezcan, G. |
|
2014 |
50 |
S5 |
p. S182-S183 2 p. |
artikel |
317 |
Floorplans
|
|
|
2014 |
50 |
S5 |
p. xxi-xxii nvt p. |
artikel |
318 |
620: Fluorescence analysis of urine: Role in differential diagnostics between benign and malignant ovarian tumours
|
Martinicky, D. |
|
2014 |
50 |
S5 |
p. S147-S148 2 p. |
artikel |
319 |
964: FokI and TakI vitamin D receptor polymorphism in patients with prostate cancer
|
Kwiatkowski, R. |
|
2014 |
50 |
S5 |
p. S235- 1 p. |
artikel |
320 |
166: FoxF1 is a potential oncogene in prostate cancer
|
Nowak, M. |
|
2014 |
50 |
S5 |
p. S37- 1 p. |
artikel |
321 |
952: Frequency of KRAS and NRAS mutations in Bulgarian patients with colorectal cancer
|
Bichev, S. |
|
2014 |
50 |
S5 |
p. S232- 1 p. |
artikel |
322 |
183: From ERa66 to ERa36: a new predictive marker for cancer progression and therapeutic response in breast tumors?
|
Chamard, C. |
|
2014 |
50 |
S5 |
p. S41- 1 p. |
artikel |
323 |
30: From the immune contexture to the Immunoscore in cancer
|
Galon, J. |
|
2014 |
50 |
S5 |
p. S8- 1 p. |
artikel |
324 |
811: Fully human antibodies specific for oxidized macrophage migration inhibitory factor (oxMIF) exhibit anti-cancer activity in animal models
|
Thiele, M. |
|
2014 |
50 |
S5 |
p. S196- 1 p. |
artikel |
325 |
955: Functional germline variants in driver genes of breast cancer
|
Göhler, S. |
|
2014 |
50 |
S5 |
p. S233- 1 p. |
artikel |
326 |
11: Functional heterogeneity of tumour-initiating cells in gastrointestinal cancers
|
|
|
2014 |
50 |
S5 |
p. S4- 1 p. |
artikel |
327 |
65: Functional interplay between the DNA damage response and ARF pathways in human cancer
|
Gorgoulis, V.G. |
|
2014 |
50 |
S5 |
p. S16- 1 p. |
artikel |
328 |
504: Functional proteomic analysis of leukaemogenic protein tyrosine kinase targets
|
Che Azmi, N. |
|
2014 |
50 |
S5 |
p. S121-S122 2 p. |
artikel |
329 |
420: Functional role of the long noncoding RNA ANRIL in silencing of the INK4/ARF tumor suppressor locus in urothelial carcinoma
|
Hoffmann, M. |
|
2014 |
50 |
S5 |
p. S100-S101 2 p. |
artikel |
330 |
208: GALNT1 knockdown suppresses hepatocellular carcinoma cell malignant behaviours and decreases EGFR activation and recycling
|
Huang, M. |
|
2014 |
50 |
S5 |
p. S47- 1 p. |
artikel |
331 |
206: GDF15 knockdown induces resistance to temozolomide treatment in glioblastoma cell line
|
Baroni, M. |
|
2014 |
50 |
S5 |
p. S47- 1 p. |
artikel |
332 |
307: Gelsolin promotes the survival of cancer cells under stress by modulating autophagy
|
Deng, S. |
|
2014 |
50 |
S5 |
p. S73- 1 p. |
artikel |
333 |
698: Gene expression of SOX2, SOX6, SOX8 and SOX9 and their prognostic role in patients with gliomas
|
Stancheva, G. |
|
2014 |
50 |
S5 |
p. S168- 1 p. |
artikel |
334 |
General Information
|
|
|
2014 |
50 |
S5 |
p. x-xiii nvt p. |
artikel |
335 |
449: Gene-specific methylation profiles in male breast cancer
|
Rizzolo, P. |
|
2014 |
50 |
S5 |
p. S108-S109 2 p. |
artikel |
336 |
948: Genetic variants of susceptibility in second primary esophageal cancer patients
|
Boldrin, E. |
|
2014 |
50 |
S5 |
p. S231- 1 p. |
artikel |
337 |
461: Genomic copy number and microRNA profiles of 27 colon cancer cell lines
|
Berg, K.G. |
|
2014 |
50 |
S5 |
p. S111- 1 p. |
artikel |
338 |
440: Genomic copy number changes and the prognostic impact of the encoded genes PTEN and BIRC5 in malignant peripheral nerve sheath tumours
|
Høland, M. |
|
2014 |
50 |
S5 |
p. S106- 1 p. |
artikel |
339 |
422: Genomic structural instability and homologous recombination deficiency in breast and ovarian cancers
|
Popova, T. |
|
2014 |
50 |
S5 |
p. S101- 1 p. |
artikel |
340 |
570: Global DNA methylation profiling identifies epigenetic differences between spontaneous and radiation-induced rat mammary carcinomas
|
Takabatake, M. |
|
2014 |
50 |
S5 |
p. S137- 1 p. |
artikel |
341 |
599: GLUT-1 inhibition: A new therapeutic approach against hepatocellular carcinoma?
|
Brito, A.F. |
|
2014 |
50 |
S5 |
p. S144- 1 p. |
artikel |
342 |
696: Glycoprofiling of serous ovarian tumours is a promising strategy for developing new diagnostic tools
|
Ricardo, S. |
|
2014 |
50 |
S5 |
p. S167- 1 p. |
artikel |
343 |
743: Gold nanoparticle conjugated lignan derivatives inhibited the proliferation of MCF-7 human breast cancer cells
|
Bakar, F. |
|
2014 |
50 |
S5 |
p. S178-S179 2 p. |
artikel |
344 |
513: GPR84 is a positive regulator of beta-catenin signalling and is required for the maintenance of MLLAF9-rearranged acute myeloid leukaemia
|
Dietrich, P.A. |
|
2014 |
50 |
S5 |
p. S123-S124 2 p. |
artikel |
345 |
102: Growth-inhibitory effect of conjugated linolenic acid on human eosinophilic leukemia EoL-1 cells
|
Liu, W.N. |
|
2014 |
50 |
S5 |
p. S23-S24 2 p. |
artikel |
346 |
990: Hair dyes in breast cancer risk
|
Heikkinen, S. |
|
2014 |
50 |
S5 |
p. S241- 1 p. |
artikel |
347 |
82: Hallmarks of cancer: applications to cancer medicine?
|
Hanahan, D. |
|
2014 |
50 |
S5 |
p. S21- 1 p. |
artikel |
348 |
953: HDAC9 inhibition decreases cell proliferation in acute lymphoblastic leukemia
|
Moreno, D. |
|
2014 |
50 |
S5 |
p. S232- 1 p. |
artikel |
349 |
684: Helsinki Urological Biobank (HUB): A new-generation integrated biobank for facilitating precision medicine and translational research in urological cancers
|
Af Hällström, T. |
|
2014 |
50 |
S5 |
p. S164- 1 p. |
artikel |
350 |
410: HER2 binds to the genome at specific regulatory sites of key genes in breast cancer
|
Redmond, A. |
|
2014 |
50 |
S5 |
p. S98- 1 p. |
artikel |
351 |
967: Hereditary variants of genes coding for TP53 and its regulators (CHK2 and WIP1) in high-risk breast cancer patients
|
Kleiblova, P. |
|
2014 |
50 |
S5 |
p. S236- 1 p. |
artikel |
352 |
662: HER2 isoforms in mammary carcinogenesis and targeted therapy susceptibility
|
Palladini, A. |
|
2014 |
50 |
S5 |
p. S158- 1 p. |
artikel |
353 |
486: HER-2 overexpression is closely related with genes that belong to the Shh pathway in medulloblastoma
|
Cruzeiro, G.A.V. |
|
2014 |
50 |
S5 |
p. S117- 1 p. |
artikel |
354 |
522: Her-receptor ligands and their role in cetuximab sensitivity in gastric cancer
|
Kneissl, J. |
|
2014 |
50 |
S5 |
p. S126- 1 p. |
artikel |
355 |
191: Heterogeneity among early-stage K-Ras driven lung adenocarcinoma predicts tumor aggressiveness and identifies Ddr1 as a therapeutic target
|
Ambrogio, C. |
|
2014 |
50 |
S5 |
p. S43-S44 2 p. |
artikel |
356 |
732: Heterogeneous response to bevacizumab combined with chemotherapy in patient-derived ovarian cancer xenografts
|
Decio, A. |
|
2014 |
50 |
S5 |
p. S176- 1 p. |
artikel |
357 |
223: HIF prolyl hydroxylase PHD3 maintains hypoxic cell cycle through cyclin-dependent kinase inhibitor P27
|
Högel, H. |
|
2014 |
50 |
S5 |
p. S51- 1 p. |
artikel |
358 |
658: High-grade serous ovarian cancer subtyping identifies pathways for targeted therapy
|
Huhtinen, K. |
|
2014 |
50 |
S5 |
p. S157- 1 p. |
artikel |
359 |
593: High incidence of EGFR gene mutations in Serbian female lung adenocarcinoma patients
|
Cavic, M. |
|
2014 |
50 |
S5 |
p. S143- 1 p. |
artikel |
360 |
987: High intensity of cytoplasmic peroxiredoxin VI predicts poor outcome in diffuse large B-cell lymphoma
|
Kuusisto, M.E.L. |
|
2014 |
50 |
S5 |
p. S241- 1 p. |
artikel |
361 |
991: Highly sensitive pancreatic cancer diagnosis by serum exosome stem cell and miRNA markers
|
Zöller, M. |
|
2014 |
50 |
S5 |
p. S241- 1 p. |
artikel |
362 |
150: High selective cytotoxic activity of sesamol induced mitochondrialmediated apoptosis pathway in lung adenocarcinoma cells
|
Siriwarin, B. |
|
2014 |
50 |
S5 |
p. S33- 1 p. |
artikel |
363 |
264: Histone deacetylase inhibitors resensitize glioblastoma cells to EGFR-directed therapy with tyrosine kinase inhibitors after primary treatment failure
|
Liffers, K. |
|
2014 |
50 |
S5 |
p. S62- 1 p. |
artikel |
364 |
51: How T cells may distinguish stress from normality in an epithelium
|
Hayday, A. |
|
2014 |
50 |
S5 |
p. S13- 1 p. |
artikel |
365 |
847: Hsp90 inhibitor–drug conjugates (HDCs): concept and preclinical activity
|
Ying, W. |
|
2014 |
50 |
S5 |
p. S206- 1 p. |
artikel |
366 |
750: Human amniotic membrane secreted factors plus chemotherapy: A mishmash of effects?
|
Guerra, S. |
|
2014 |
50 |
S5 |
p. S180- 1 p. |
artikel |
367 |
818: Human antibodies specific for oxidized macrophage migration inhibitory factor (oxMIF) synergize with chemotherapeutic agents in animal models of cancer
|
Voelkel, D. |
|
2014 |
50 |
S5 |
p. S198- 1 p. |
artikel |
368 |
765: Human recombinant arginase I (Co)-PEG5000 [HuArgI (Co)-PEG5000]-induced arginine depletion is selectively cytotoxic to human glioblastoma cells
|
Khoury, O. |
|
2014 |
50 |
S5 |
p. S184- 1 p. |
artikel |
369 |
308: Hybrid peptide tat-Ram13-induced necrosis-like cell death depends on expression of PTEN in human leukemia cell lines
|
Kuniyasu, A. |
|
2014 |
50 |
S5 |
p. S73- 1 p. |
artikel |
370 |
544: 2-Hydroxyethyl methacrylate-dependent cytotoxicity: A gene expression study
|
Di Nisio, C. |
|
2014 |
50 |
S5 |
p. S131-S132 2 p. |
artikel |
371 |
983: Hypermethylation biomarkers associated with inorganic arsenic metabolism are predictors to the occurrence of internal organ cancers among arseniasis residents
|
Liao, P. |
|
2014 |
50 |
S5 |
p. S240- 1 p. |
artikel |
372 |
780: Hyperthermia-mediated local drug delivery by a bubble-generating liposomal system for tumor specific chemotherapy
|
Sung, H.W. |
|
2014 |
50 |
S5 |
p. S187-S188 2 p. |
artikel |
373 |
836: Hyperthermia potentiates cisplatin and doxorubicin effects by inhibition of PARP-dependent DNA repair
|
Schaaf, L. |
|
2014 |
50 |
S5 |
p. S203- 1 p. |
artikel |
374 |
737: ICP-133 controls in vitro cell proliferation of multiple myeloma cancer stem cells
|
Issa, M. |
|
2014 |
50 |
S5 |
p. S176-S177 2 p. |
artikel |
375 |
235: Identification and characterization of novel cancer-associated molecules
|
Chernenko, A. |
|
2014 |
50 |
S5 |
p. S54-S55 2 p. |
artikel |
376 |
328: Identification and quantification of BRCA1 splicing variants
|
Lhota, F. |
|
2014 |
50 |
S5 |
p. S78- 1 p. |
artikel |
377 |
437: Identification of a specific and sensitive urinary DNA hypermethylation signature for bladder cancer diagnosis
|
Köhler, C.U. |
|
2014 |
50 |
S5 |
p. S105- 1 p. |
artikel |
378 |
431: Identification of deregulated genes in colorectal cancer metastasis through whole genome and transcriptome sequencing
|
Hauser, C. |
|
2014 |
50 |
S5 |
p. S103- 1 p. |
artikel |
379 |
322: Identification of GREB1 as a potential mediator of estrogen effects on ovarian cancer progression in a mouse model
|
Hodgkinson, K.M. |
|
2014 |
50 |
S5 |
p. S77- 1 p. |
artikel |
380 |
435: Identification of hypoxia-induced miRNAs in colon cancer stem cells
|
Ullmann, P. |
|
2014 |
50 |
S5 |
p. S104-S105 2 p. |
artikel |
381 |
523: Identification of kallikrein-related peptidase 7 degradome and transcriptome targets in ovarian cancer
|
Munasinghage Silva, L. |
|
2014 |
50 |
S5 |
p. S126- 1 p. |
artikel |
382 |
554: Identification of molecular targets and signalling networks that influence hypersensitivity to ionizing radiation
|
Michna, A. |
|
2014 |
50 |
S5 |
p. S134- 1 p. |
artikel |
383 |
655: Identification of new synergistic drug combinations on basis of cell panel profiling
|
Uitdehaag, J.C.M. |
|
2014 |
50 |
S5 |
p. S156- 1 p. |
artikel |
384 |
529: Identification of novel determinants of cetuximab-resistance in triple negative breast cancer
|
Albukhari, A. |
|
2014 |
50 |
S5 |
p. S128- 1 p. |
artikel |
385 |
459: Identification of novel epigenetic modulators of acquired chemoresistance in colon cancer
|
Enreig, E. |
|
2014 |
50 |
S5 |
p. S111- 1 p. |
artikel |
386 |
959: Identification of pathogenic mutations in RAD51 paralogs in BRCA1/2-negative ovarian cancer patients in the Czech Republic
|
Janatova, M. |
|
2014 |
50 |
S5 |
p. S234- 1 p. |
artikel |
387 |
382: Identification of pathogenic virus sequences in pancreatic cancer
|
Amaravadi, M. |
|
2014 |
50 |
S5 |
p. S91- 1 p. |
artikel |
388 |
980: Identification of potential biomarkers in pancreatic ductal adenocarcinoma associated to tumor–stroma interaction
|
Resovi, A. |
|
2014 |
50 |
S5 |
p. S239- 1 p. |
artikel |
389 |
899: Identifying genes involved in the colon cancer initiating cells (CICs) survivability against montelukast treatment in xenograft model
|
Bellamkonda, K. |
|
2014 |
50 |
S5 |
p. S220- 1 p. |
artikel |
390 |
181: IGF family genes expression in clear cell renal cell cancer and their corresponding adjacent non-cancerous kidney tissues
|
Braczkowski, R.S. |
|
2014 |
50 |
S5 |
p. S41- 1 p. |
artikel |
391 |
100: IKKb dependent NF-kB activation suppresses progression of lung metastases during breast carcinogenesis
|
Fang, H.Y. |
|
2014 |
50 |
S5 |
p. S23- 1 p. |
artikel |
392 |
79: Imaging as tool for translational research in oncology
|
Schwaiger, M. |
|
2014 |
50 |
S5 |
p. S19-S20 2 p. |
artikel |
393 |
536: Immunofluorescent analysis and estimation of clinical significance of ERCC1 expression in ovarian cancer tissue
|
Semakov, A.V. |
|
2014 |
50 |
S5 |
p. S129-S130 2 p. |
artikel |
394 |
927: Immunohistochemical analysis reveals frequent tumoural loss of ATM protein expression in lung cancer
|
Weber, A.M. |
|
2014 |
50 |
S5 |
p. S227- 1 p. |
artikel |
395 |
622: Immunohistochemical evaluation of the mammalian target of rapamycin pathway in stage I non-small cell lung carcinoma
|
Kim, H.R. |
|
2014 |
50 |
S5 |
p. S148- 1 p. |
artikel |
396 |
867: Immuno-modulatory effect of the photosensitizer BAM-SiPc in cancer treatment
|
Yeung, H.Y. |
|
2014 |
50 |
S5 |
p. S212- 1 p. |
artikel |
397 |
898: Impact of inflammation in a spontaneous model of melanoma in zebrafish
|
Gómez-Abenza, E. |
|
2014 |
50 |
S5 |
p. S220- 1 p. |
artikel |
398 |
152: Impact of the microenvironment on therapeutics in breast cancer
|
Lovitt, C.J. |
|
2014 |
50 |
S5 |
p. S33-S34 2 p. |
artikel |
399 |
631: Impact of TP53 accumulation on ovarian cancer prognosis in BRCA1 mutation carriers
|
Rzepecka, I.K. |
|
2014 |
50 |
S5 |
p. S150-S151 2 p. |
artikel |
400 |
921: Importance of Mcl-1 and the Mcl-1-modulating enzyme USP9x for radiosensitivity in prostate cancer cells
|
Rudner, J. |
|
2014 |
50 |
S5 |
p. S225-S226 2 p. |
artikel |
401 |
916: Importance of stromal caveolin-1 for tumor growth and radiosensitivity of epithelial tumors
|
Verhelst, V. |
|
2014 |
50 |
S5 |
p. S224- 1 p. |
artikel |
402 |
825: Improved cytotoxic therapy by dual targeting of a5β1 integrin and p53 pathway in glioblastoma
|
Dontenwill, M. |
|
2014 |
50 |
S5 |
p. S199-S200 2 p. |
artikel |
403 |
287: Improved robustness for fully automated 3D spheroid HCA screening
|
Degot, S. |
|
2014 |
50 |
S5 |
p. S68- 1 p. |
artikel |
404 |
456: Improving cell based models through viral vector technology - chances for functional genomics and target research
|
Schmitt, K. |
|
2014 |
50 |
S5 |
p. S110- 1 p. |
artikel |
405 |
219: Inactivation of nucleoside-derived anticancer drugs by catabolic prokaryotic enzymes
|
Vande Voorde, J. |
|
2014 |
50 |
S5 |
p. S50- 1 p. |
artikel |
406 |
946: Incidence of second malignancies for prostate cancer in the canton of Zurich, 1980-2010
|
Van Hemelrijck, M. |
|
2014 |
50 |
S5 |
p. S230-S231 2 p. |
artikel |
407 |
945: Increased overall risk of cancer in patients with type 2 diabetes mellitus, but not their siblings or spouses
|
Liu, X. |
|
2014 |
50 |
S5 |
p. S230- 1 p. |
artikel |
408 |
843: Increasing the efficacy of photodynamic therapy of solid cancers by inhibition of hypoxic signaling with acriflavine
|
Broekgaarden, M. |
|
2014 |
50 |
S5 |
p. S205- 1 p. |
artikel |
409 |
Index of presenting authors
|
|
|
2014 |
50 |
S5 |
p. S243-S247 5 p. |
artikel |
410 |
47: Individualised systems medicine for cancer care
|
|
|
2014 |
50 |
S5 |
p. S12- 1 p. |
artikel |
411 |
831: Induction of apoptosis by pyrrolo-1,5-benzoxazepines in oral squamous carcinoma cells
|
O’Callaghan, K. |
|
2014 |
50 |
S5 |
p. S201- 1 p. |
artikel |
412 |
779: Induction of cavitation by a bubble-generating liposomal system for physical cancer therapy
|
Chung, M.F. |
|
2014 |
50 |
S5 |
p. S187- 1 p. |
artikel |
413 |
138: Induction of cellular senescence and hair follicle stem cell dysfunction upon p14ARF and p16Ink4a expression in the skin
|
Azazmeh, N. |
|
2014 |
50 |
S5 |
p. S31- 1 p. |
artikel |
414 |
298: Induction of HIF1a influences estrogen receptor expression in ex-vivo culture of tumour tissue
|
Davies, E. |
|
2014 |
50 |
S5 |
p. S70-S71 2 p. |
artikel |
415 |
530: Induction of survival pathways in human cholangiocarcinoma cells following photodynamic therapy
|
Weijer, R. |
|
2014 |
50 |
S5 |
p. S128- 1 p. |
artikel |
416 |
86: Infections causing human cancers – mechanisms and perspectives
|
zur Hausen, H. |
|
2014 |
50 |
S5 |
p. S22- 1 p. |
artikel |
417 |
72: Inflammation in colorectal and liver tumorigenesis
|
Karin, M. |
|
2014 |
50 |
S5 |
p. S18- 1 p. |
artikel |
418 |
316: Influence of cancer stem cells on drug resistance in prostate cancer
|
Castellón, E.A. |
|
2014 |
50 |
S5 |
p. S75- 1 p. |
artikel |
419 |
957: Inherited variants in genes somatically mutated in thyroid cancer
|
Campo, C. |
|
2014 |
50 |
S5 |
p. S233- 1 p. |
artikel |
420 |
835: Inhibiting MTH1 kills cancer cells by preventing sanitisation of oxidised dNTP pool
|
Warpman Berglund, U. |
|
2014 |
50 |
S5 |
p. S203- 1 p. |
artikel |
421 |
671: Inhibition of angiogenesis promotes a homogeneous intra-tumor distribution of chemotherapy associated with better antitumor response
|
Cesca, M. |
|
2014 |
50 |
S5 |
p. S161- 1 p. |
artikel |
422 |
862: Inhibition of carbonic anhydrases 9/12 decreases proliferation leading to cell death in vitro and in vivo and enhances chemosensitivity in glioblastoma cells
|
Teixeira, S. |
|
2014 |
50 |
S5 |
p. S210-S211 2 p. |
artikel |
423 |
776: Inhibition of the IRE-1/XBP-1 pathway synergizes with ibrutinib for the treatment of B cell cancer
|
Tang, C.H. |
|
2014 |
50 |
S5 |
p. S186-S187 2 p. |
artikel |
424 |
329: Inhibition of thioredoxin-1 by small interfering RNA reduces chemoresistance for doxorubicine in two diffuse large B-cell lymphoma cell lines
|
Kuusisto, M.E.L. |
|
2014 |
50 |
S5 |
p. S78- 1 p. |
artikel |
425 |
816: Inhibitory effect of xanthohumol on STAT3 activation and cholangiocarcinoma development
|
Dokduang, H. |
|
2014 |
50 |
S5 |
p. S197- 1 p. |
artikel |
426 |
Innovation Launch Special Session
|
|
|
2014 |
50 |
S5 |
p. xxxi- 1 p. |
artikel |
427 |
893: In situ tumor ablation by intratumoral pulsed electric currents and activation of systemic anti-tumor immunity
|
Keisari, Y. |
|
2014 |
50 |
S5 |
p. S218- 1 p. |
artikel |
428 |
950: Intake and potential cancer risk of polycyclic aromatic hydrocarbons associated with traditional grilled meat consumption in Iran
|
Ahmadkhaniha, R. |
|
2014 |
50 |
S5 |
p. S231-S232 2 p. |
artikel |
429 |
331: Integrative analysis reveals extensive association between microRNA expression and mRNA–protein translation
|
Aure, M.R. |
|
2014 |
50 |
S5 |
p. S79- 1 p. |
artikel |
430 |
118: Interaction of C-FABP and PPARS in prostate cancer
|
Seyed Forootan, F. |
|
2014 |
50 |
S5 |
p. S26-S27 2 p. |
artikel |
431 |
491: Interaction of Hedgehog-Gli and estrogen receptor signaling pathways in breast cancer cells
|
Levanat, S. |
|
2014 |
50 |
S5 |
p. S118- 1 p. |
artikel |
432 |
880: Interactions of immunoglobulin-like cell adhesion molecule hepaCAM with CD137 in cell-matrix interactions, cell motility and escape from immune surveillance in Hodgkin Lymphoma
|
Seah, J. |
|
2014 |
50 |
S5 |
p. S215- 1 p. |
artikel |
433 |
663: Inter- and intra-tumoral heterogeneity in oncogenic activation of PI3K and MAPK pathways in aggressive thyroid carcinomas (PDC and ATC) - Cohabitation rate
|
Muñoz Martínez, R. |
|
2014 |
50 |
S5 |
p. S158-S159 2 p. |
artikel |
434 |
164: Interplay between EMT-inducers and miRNAs during breast tumorigenesis
|
Moyret-Lalle, C. |
|
2014 |
50 |
S5 |
p. S36- 1 p. |
artikel |
435 |
854: Interplay between mTOR pathway and Unfolded Protein Response in stress response of neuroendocrine tumors: a possible key to enhance tumors response to targeted therapy?
|
Freis, P. |
|
2014 |
50 |
S5 |
p. S208- 1 p. |
artikel |
436 |
10: Intra-tumour heterogeneity in early-stage lung cancer inferred by multi-region sequencing
|
De Bruin, E. |
|
2014 |
50 |
S5 |
p. S4- 1 p. |
artikel |
437 |
693: Intrinsic resistance to sunitinib in clear cell renal cell carcinoma: A gene expression analysis
|
Reig, O. |
|
2014 |
50 |
S5 |
p. S167- 1 p. |
artikel |
438 |
566: Investigating PI3Kinase and K-ras pathway interactions in mouse model of colorectal cancer
|
Meniel, V. |
|
2014 |
50 |
S5 |
p. S136- 1 p. |
artikel |
439 |
906: Investigating the cellular and molecular mechanisms of tumour and host immune response to ionizing irradiation in zebrafish
|
Aylott, I.N. |
|
2014 |
50 |
S5 |
p. S222- 1 p. |
artikel |
440 |
520: Investigation of the expression and the role of avβ3, avβ5 and a5β1 integrins in head and neck cancers
|
Ahmedah, H. |
|
2014 |
50 |
S5 |
p. S125- 1 p. |
artikel |
441 |
791: Investigation of the mode of action of sunitinib kinase inhibitor profile analogues in insulin release
|
Orfi, Z. |
|
2014 |
50 |
S5 |
p. S190-S191 2 p. |
artikel |
442 |
904: Investigation on the role of low dose radiation as chemo-potentiator in locally advanced carcinoma cervix: A new treatment paradigm based on radiobiological advantage
|
Das, S. |
|
2014 |
50 |
S5 |
p. S221- 1 p. |
artikel |
443 |
817: Investigations into the anti-cancer mechanism of action of garlic related disulfides
|
Kaschula, C.H. |
|
2014 |
50 |
S5 |
p. S197-S198 2 p. |
artikel |
444 |
660: In vitro model for DNA double-strand break (DSB) repair analysis in cells derived from breast cancer specimens identifies new prognostic markers
|
Deniz, M. |
|
2014 |
50 |
S5 |
p. S158- 1 p. |
artikel |
445 |
294: In vitro modulation of CITED4 gene expression in a colorectal cancer cell line
|
Rogers, M.A. |
|
2014 |
50 |
S5 |
p. S69-S70 2 p. |
artikel |
446 |
345: In vivo model of dormancy in ER breast cancer to bone metastasis
|
Gawrzak, S. |
|
2014 |
50 |
S5 |
p. S82- 1 p. |
artikel |
447 |
624: In vivo models of pancreatic cancer for translational medicine
|
Behrens, D. |
|
2014 |
50 |
S5 |
p. S148-S149 2 p. |
artikel |
448 |
25: In vivo RNAi screening for novel therapeutic cancer targets
|
Peeper, D. |
|
2014 |
50 |
S5 |
p. S7- 1 p. |
artikel |
449 |
190: Involvement of CHK2 kinase in pre-mRNA splicing
|
Choi, H.H. |
|
2014 |
50 |
S5 |
p. S43- 1 p. |
artikel |
450 |
722: Iron chelation by biopolymers for an anti-cancer therapy; binding up the 'ferrotoxicity' in the colon
|
Horniblow, R. |
|
2014 |
50 |
S5 |
p. S173- 1 p. |
artikel |
451 |
149: Is 18F-FDG uptake in three different colon cancer cell lines affected by incubation with sodium butyrate?
|
Gonçalves, T.J. |
|
2014 |
50 |
S5 |
p. S33- 1 p. |
artikel |
452 |
918: Is single amino acid arginine deprivation a strategy to treat non-auxotrophic glioblastoma?
|
Ingargiola, M. |
|
2014 |
50 |
S5 |
p. S225- 1 p. |
artikel |
453 |
947: Italianity is associated with lower risk of prostate cancer mortality in Switzerland
|
Richard, A. |
|
2014 |
50 |
S5 |
p. S231- 1 p. |
artikel |
454 |
606: JK-1(FAM134B) gene implications in colorectal carcinoma: A gene expression and functional study
|
Kasem, K. |
|
2014 |
50 |
S5 |
p. S146- 1 p. |
artikel |
455 |
209: K06, a novel CD43 epitope on human thymocytes, is involved in caspase-independent cell death
|
Kim, T.J. |
|
2014 |
50 |
S5 |
p. S47-S48 2 p. |
artikel |
456 |
577: Lats1 knockout mouse model recapitulating human dedifferentiated liposarcoma
|
Kim, S. |
|
2014 |
50 |
S5 |
p. S139- 1 p. |
artikel |
457 |
Letter of Welcome
|
|
|
2014 |
50 |
S5 |
p. vii- 1 p. |
artikel |
458 |
484: Leukocyte cell-derived chemotaxin 2 antagonizes MET receptor activation and results in the suppression of hepatocellular carcinoma vascular invasion
|
Hua, K.T. |
|
2014 |
50 |
S5 |
p. S116- 1 p. |
artikel |
459 |
487: Liaison between signaling and metabolism in ovarian cancer: ErbB/PI3K and fatty acid synthase
|
Grunt, T. |
|
2014 |
50 |
S5 |
p. S117- 1 p. |
artikel |
460 |
685: Linking tumor evolution and therapy response using diagnostic targeted next generation sequencing in colorectal cancer
|
Mamlouk, S. |
|
2014 |
50 |
S5 |
p. S165- 1 p. |
artikel |
461 |
List of Exhibitors
|
|
|
2014 |
50 |
S5 |
p. xxiii- 1 p. |
artikel |
462 |
545: Lithium downregulates PTEN by activating Wnt/β-catenin signaling but prevents the tumorigenic potential of colorectal cancer cells
|
Wallace, A.W. |
|
2014 |
50 |
S5 |
p. S132- 1 p. |
artikel |
463 |
711: Live imaging of cellular signaling in patient-derived tumor organoids
|
Verissimo, C. |
|
2014 |
50 |
S5 |
p. S171-S172 2 p. |
artikel |
464 |
490: Long chain alkylphenol mixture promotes mammary epithelial cell metaplastic phenotype through an estrogen receptor alpha 36 mediated mechanism
|
Chamard, C. |
|
2014 |
50 |
S5 |
p. S118- 1 p. |
artikel |
465 |
52: Long non-coding RNA and cancer
|
Diederichs, S. |
|
2014 |
50 |
S5 |
p. S13- 1 p. |
artikel |
466 |
334: Long-term inhibition of miR-200c in pancreatic adenocarcinoma cells changes CDH1 expression and cell migration
|
Stölting, M. |
|
2014 |
50 |
S5 |
p. S79- 1 p. |
artikel |
467 |
128: Loss of far upstream element (FUSE) binding protein (FBP)- interacting repressor (FIR) function supports HCC growth
|
Malz, M. |
|
2014 |
50 |
S5 |
p. S28- 1 p. |
artikel |
468 |
300: Loss of PI3K-C2a promotes tumorigenesis and aneuploidy in breast cancer
|
Martini, M. |
|
2014 |
50 |
S5 |
p. S71- 1 p. |
artikel |
469 |
961: Low-penetrance alleles and male breast cancer risk: Results from a multicenter study in Italy
|
Silvestri, V. |
|
2014 |
50 |
S5 |
p. S234- 1 p. |
artikel |
470 |
370: Lymphotoxin signalling alters the vasculature to increase tumour cell metastasis
|
Simonavicius, N. |
|
2014 |
50 |
S5 |
p. S88- 1 p. |
artikel |
471 |
875: Macrophage migration and polarization is triggered by oxygen gradient in glioblastoma
|
Leblond, M.M. |
|
2014 |
50 |
S5 |
p. S214- 1 p. |
artikel |
472 |
17: Magnetic resonance imaging of tumour metabolism
|
Brindle, K.M. |
|
2014 |
50 |
S5 |
p. S5-S6 2 p. |
artikel |
473 |
339: MALDI-MS peptide profiling of thyroid cancer cell lines to detect peptide signatures changes with the PI3-K inhibitor GDC-0941, in hypoxia and normoxia
|
Henderson, F. |
|
2014 |
50 |
S5 |
p. S80-S81 2 p. |
artikel |
474 |
396: Malignant transformation in high hyperdiploid pediatric acute lymphoblastic leukemia (HHDpALL) is characteristically featured with sequential and hierarchical numerical chromosomal changes, and chromosomal instability (CIN)
|
Alpar, D.R. |
|
2014 |
50 |
S5 |
p. S94-S95 2 p. |
artikel |
475 |
123: M30 assay may not be an accurate method for apoptosis in the cancer cells expressing low level of cytokeratin
|
Cevatemre, B. |
|
2014 |
50 |
S5 |
p. S27- 1 p. |
artikel |
476 |
768: MDR1 confers the acquired resistance to 17-DMAG in lung cancer with ALK rearrangement
|
Choi, C. |
|
2014 |
50 |
S5 |
p. S184- 1 p. |
artikel |
477 |
470: Mechanism of tumourigenesis caused by loss of SMARCB1 in malignant rhabdoid tumors
|
Finetti, M. |
|
2014 |
50 |
S5 |
p. S113-S114 2 p. |
artikel |
478 |
22: Mechanisms and biomarkers of acquired resistance to targeted cancer therapies
|
|
|
2014 |
50 |
S5 |
p. S7- 1 p. |
artikel |
479 |
489: Mechanisms linking obesity to altered metabolism in colon carcinogenesis
|
Nimri, L. |
|
2014 |
50 |
S5 |
p. S117-S118 2 p. |
artikel |
480 |
83: Mechanisms of metastasis by colorectal cancer stem cells
|
Batlle, E. |
|
2014 |
50 |
S5 |
p. S21- 1 p. |
artikel |
481 |
628: MED15 in head and neck squamous cell carcinoma: Clinical and molecular implications
|
Offermann, A. |
|
2014 |
50 |
S5 |
p. S150- 1 p. |
artikel |
482 |
627: MED12 overexpression is a frequent event in castration-resistant prostate cancer
|
Offermann, A. |
|
2014 |
50 |
S5 |
p. S149- 1 p. |
artikel |
483 |
949: Melatonin secretion in patients with breast cancer associated with primary hypertension
|
Tavartkiladze, A. |
|
2014 |
50 |
S5 |
p. S231- 1 p. |
artikel |
484 |
804: Meripilus giganteus in prevention of cancer: Phenolic profile, biological potential and antitumor effect via upregulation of p53 and SOX1 expression in HeLa cells
|
Petrovic, I. |
|
2014 |
50 |
S5 |
p. S194- 1 p. |
artikel |
485 |
84: Mesenchymal and MDS stem cells shape an interactive disease unit in the bone marrow
|
Trumpp, A. |
|
2014 |
50 |
S5 |
p. S21- 1 p. |
artikel |
486 |
267: Mesenchymal cells regulate growth of intestinal crypts by a Wnt independent mechanism in 3D culture system
|
Pastula, A. |
|
2014 |
50 |
S5 |
p. S63- 1 p. |
artikel |
487 |
902: Mesenchymal stem cell therapy antagonizes radiation-induced endothelial cell damage and metastasis
|
Klein, D. |
|
2014 |
50 |
S5 |
p. S221- 1 p. |
artikel |
488 |
163: Metabolic activity of tumor cells in a variable microenvironment: combinations of glucose, glutamine, lactate and pH
|
Otto, A.M. |
|
2014 |
50 |
S5 |
p. S36- 1 p. |
artikel |
489 |
126: Metabolic and motile reprogramming of ER positive breast cancer cells following long-term estrogen deprivation
|
Morandi, A. |
|
2014 |
50 |
S5 |
p. S28- 1 p. |
artikel |
490 |
746: Metabolic radiotherapy in cholangiocarcinoma: An option in the future?
|
Fernandes, A.I. |
|
2014 |
50 |
S5 |
p. S179- 1 p. |
artikel |
491 |
586: Metallothionein up-regulation in response to cadmium exposure in a normal human urothelial cell system
|
McNeill, R. |
|
2014 |
50 |
S5 |
p. S141- 1 p. |
artikel |
492 |
299: Metformin induces apoptosis and dowregulates pyruvate kinase M2 in MCF7 breast cancer cells only when grown in nutrient-poor conditions
|
Silvestri, A. |
|
2014 |
50 |
S5 |
p. S71- 1 p. |
artikel |
493 |
140: MET signaling in colorectal cancer-initiating cells blunts response to EGFR inhibition: Implications for targeted therapy
|
Luraghi, P. |
|
2014 |
50 |
S5 |
p. S31- 1 p. |
artikel |
494 |
928: Met signaling sustains glioblastoma stem cells radioresistance
|
De Bacco, F. |
|
2014 |
50 |
S5 |
p. S227-S228 2 p. |
artikel |
495 |
353: microRNA-449 acts as a barrier to stemness
|
Gallinas Suazo, C. |
|
2014 |
50 |
S5 |
p. S84- 1 p. |
artikel |
496 |
426: MicroRNA 196b regulates radioresistance of gastric cancer cells by targeting HR23B
|
Kim, S. |
|
2014 |
50 |
S5 |
p. S102- 1 p. |
artikel |
497 |
285: MicroRNA expression in triple-negative versus other subtypes of breast cancer
|
Kalniete, D. |
|
2014 |
50 |
S5 |
p. S67-S68 2 p. |
artikel |
498 |
832: MicroRNA-139-5p: A tool for metastasis and chemotherapeutic resistance control in pancreatic adenocarcinoma
|
Passadouro, M. |
|
2014 |
50 |
S5 |
p. S202- 1 p. |
artikel |
499 |
699: MicroRNA profiling in serum samples from donors with germ cell cancer
|
Lee, K. |
|
2014 |
50 |
S5 |
p. S168- 1 p. |
artikel |
500 |
434: MicroRNAs at the human 14q32 locus have significance in malignant phyllodes tumour
|
Kim, D.C. |
|
2014 |
50 |
S5 |
p. S104- 1 p. |
artikel |
501 |
695: MicroRNAs for detection of pancreatic neoplasia: biomarker discovery by next generation sequencing and validation in EUS FNA and plasma samples
|
Gironella, M. |
|
2014 |
50 |
S5 |
p. S167- 1 p. |
artikel |
502 |
686: microRNAs in hepatocellular carcinoma
|
Balakrishnan, A. |
|
2014 |
50 |
S5 |
p. S165- 1 p. |
artikel |
503 |
418: Microsatellite unstable neuroendocrine carcinomas are a distinct clinico-pathologic entity in the gastroenteropancreatic system
|
Furlan, D. |
|
2014 |
50 |
S5 |
p. S100- 1 p. |
artikel |
504 |
263: Mimicking the tumour microenvironment (TME): Angiogenesis in tumour progression
|
Bonda, U.H. |
|
2014 |
50 |
S5 |
p. S62- 1 p. |
artikel |
505 |
175: miR-27a is a functional biomarker for tamoxifen treatment of luminal A/B breast tumors
|
Ljepoja, B. |
|
2014 |
50 |
S5 |
p. S39- 1 p. |
artikel |
506 |
397: miR-141 and miR-375 expression in plasma samples from Bulgarian prostate cancer patients and controls
|
Kachakova, D. |
|
2014 |
50 |
S5 |
p. S95- 1 p. |
artikel |
507 |
518: miR-125b confers NF-κB activity and temozolomide resistance by targeting TNFAIP3 and NKIRAS2 in glioblastomas
|
Haemmig, S. |
|
2014 |
50 |
S5 |
p. S125- 1 p. |
artikel |
508 |
644: miRNA-mRNA integrated analysis in breast cancer: Let-7 cluster as a meta-signature for grade classification
|
Oztemur, Y. |
|
2014 |
50 |
S5 |
p. S153-S154 2 p. |
artikel |
509 |
53: miRNA-protein interaction networks in cancer
|
Wiemann, S. |
|
2014 |
50 |
S5 |
p. S13- 1 p. |
artikel |
510 |
275: MiR-136 targeting Notch3 is involved in chemoresistance and angiogenesis in ovarian cancer cells
|
An, H. |
|
2014 |
50 |
S5 |
p. S65- 1 p. |
artikel |
511 |
680: miR-187 targets the androgen-regulated gene ALDH1A3 in prostate cancer
|
Casanova-Salas, I. |
|
2014 |
50 |
S5 |
p. S163- 1 p. |
artikel |
512 |
234: MMP2 as a molecular biomarker of proficient tumor–stroma cross-talk in lung cancer
|
Baldoli, E. |
|
2014 |
50 |
S5 |
p. S54- 1 p. |
artikel |
513 |
293: MNT roles and expression in the absence of MAX
|
Lafita, M.C. |
|
2014 |
50 |
S5 |
p. S69- 1 p. |
artikel |
514 |
454: Modelling mutational landscapes of primary cancers using an in vitro cell immortalization assay
|
Olivier, M. |
|
2014 |
50 |
S5 |
p. S110- 1 p. |
artikel |
515 |
783: Modification of topoisomerases in cancer stem cells derived from MCF7 breast cancer cell line - clinical implications for cancer treatment
|
Priel, E. |
|
2014 |
50 |
S5 |
p. S188- 1 p. |
artikel |
516 |
452: Modifications in gene expression profile of mammary gland and experimental tumors by effect of high fat diets
|
Moral, R. |
|
2014 |
50 |
S5 |
p. S109- 1 p. |
artikel |
517 |
342: Modulated electrohyperthermia induced immunogenic cell death specific signals in colorectal adenocarcinoma model
|
Meggyeshazi, N. |
|
2014 |
50 |
S5 |
p. S81-S82 2 p. |
artikel |
518 |
576: Modulating the Wnt-pathway in colorectal adenoma cells by 1,25-dihydroxyvitamin D3
|
Gröschel, C. |
|
2014 |
50 |
S5 |
p. S138-S139 2 p. |
artikel |
519 |
352: Modulation of canonical WNT signaling in combination with temozolomide inhibits growth of glioblastoma cancer stem cells in vitro
|
Schneider, F. |
|
2014 |
50 |
S5 |
p. S84- 1 p. |
artikel |
520 |
588: Modulation of CXCR4/CXL12 axis by hypoxia and pharmacological drug combination in colon cancer
|
Guenot, D. |
|
2014 |
50 |
S5 |
p. S142- 1 p. |
artikel |
521 |
394: Molecular characterization through massive parallel sequencing unveils clues regarding origin of undifferentiated endometrial carcinomas
|
Rosa-Rosa, J.M. |
|
2014 |
50 |
S5 |
p. S94- 1 p. |
artikel |
522 |
77: Molecular imaging for personalised treatment of cancer
|
Oyen, W.J.G. |
|
2014 |
50 |
S5 |
p. S19- 1 p. |
artikel |
523 |
856: Molecular mechanisms of sorafenib-induced apoptosis in cancer cells
|
Kuznia, C. |
|
2014 |
50 |
S5 |
p. S209- 1 p. |
artikel |
524 |
911: Molecular mechanisms of the antineoplastic action of erufosine in hypoxic tumor cells
|
Riffkin, H. |
|
2014 |
50 |
S5 |
p. S223- 1 p. |
artikel |
525 |
548: mRNA biomarker screening in pulmonary tumors showing neuroendocrine differentiation via NanoString nCounter
|
Mairinger, F. |
|
2014 |
50 |
S5 |
p. S132- 1 p. |
artikel |
526 |
540: mTORC2, but not mTORC1, regulates chemotherapy resistance in A549 lung cancer cells
|
Chawsheen, M. |
|
2014 |
50 |
S5 |
p. S130- 1 p. |
artikel |
527 |
782: M-Trap: Exosome-based capture of tumor cells as a new therapeutic technology in peritoneal metastasis
|
Abal, M. |
|
2014 |
50 |
S5 |
p. S188- 1 p. |
artikel |
528 |
785: Multicellular tumor spheroid 3D models to decipher cancer cell biology and to evaluate anticancer drugs
|
Lobjois, V. |
|
2014 |
50 |
S5 |
p. S189- 1 p. |
artikel |
529 |
269: Multidrug resistance gene MDR1 is transactivated by Oct4 to increase chemotherapy resistance
|
Wu, C.L. |
|
2014 |
50 |
S5 |
p. S63- 1 p. |
artikel |
530 |
76: Multiparametric imaging in cancer research
|
Buck, A.K. |
|
2014 |
50 |
S5 |
p. S19- 1 p. |
artikel |
531 |
925: Multiparametric MRI evaluation of radiotherapy effects on the vascular compartment and white matter for glioblastoma treatment
|
Gerault, A. |
|
2014 |
50 |
S5 |
p. S226-S227 2 p. |
artikel |
532 |
707: Multi-point targeting of the synthetic lethal interactions between Myc, ribosome biogenesis and ribosome function cooperates to treat B-cell lymphoma
|
Pearson, R. |
|
2014 |
50 |
S5 |
p. S170-S171 2 p. |
artikel |
533 |
231: Murine tumors microenvironment after irradiation characterized by diffusion-weighted, dynamic contrast-enhanced MRI and immunohistology
|
Drzal, A. |
|
2014 |
50 |
S5 |
p. S53-S54 2 p. |
artikel |
534 |
894: Muscle mass of the host and dendritic cell phenotype in patients with colorectal cancer
|
Malietzis, G. |
|
2014 |
50 |
S5 |
p. S218- 1 p. |
artikel |
535 |
462: Mutational characterisation of 400 breast cancers genomes
|
Ramakrishna, M. |
|
2014 |
50 |
S5 |
p. S111-S112 2 p. |
artikel |
536 |
402: Mutational landscape of the mediator complex across human cancers
|
Offermann, A. |
|
2014 |
50 |
S5 |
p. S96- 1 p. |
artikel |
537 |
23: Mutations and acquired resistance in colorectal cancer
|
Bardelli, A. |
|
2014 |
50 |
S5 |
p. S7- 1 p. |
artikel |
538 |
681: Mutations and expression of genes in PI3K-AKT pathwayin radiation-induced mammary carcinoma of (Sprague-Dawley × Copenhagen) F1 hybrid rats
|
Nishimura, M. |
|
2014 |
50 |
S5 |
p. S163-S164 2 p. |
artikel |
539 |
304: Myc mediates the phosphorylation and degradation of p27 through activation of Cyclin A/CDK1
|
García-Gutiérrez, L. |
|
2014 |
50 |
S5 |
p. S72- 1 p. |
artikel |
540 |
531: MYCN induced miR-18a interferes with neuroblastoma cell differentiation by inhibition of estrogen and NGF signaling
|
Dzieran, J. |
|
2014 |
50 |
S5 |
p. S128- 1 p. |
artikel |
541 |
305: Natural and synthetic inhibitors of mTOR blunt the p53 response to low concentrations of actinomycin D but not nutlin-3
|
Goudarzi, K.M. |
|
2014 |
50 |
S5 |
p. S72- 1 p. |
artikel |
542 |
790: Netropsin inhibits the growth of Burkitt's lymphoma cells by forcing the loss of Epstein-Barr virus (EBV) genomes from those cells
|
Chakravorty, A. |
|
2014 |
50 |
S5 |
p. S190- 1 p. |
artikel |
543 |
589: New molecular markers associated with clinical outcome in locally advanced head and neck carcinoma
|
Pavon, M.A. |
|
2014 |
50 |
S5 |
p. S142- 1 p. |
artikel |
544 |
419: Next-generation sequencing to dissect transcriptome complexity of childhood ALL and of different therapy response
|
Cifola, I. |
|
2014 |
50 |
S5 |
p. S100- 1 p. |
artikel |
545 |
976: Nocturnal administration of resveratrol prevents breast cancer initiation in rats
|
Kisková, T. |
|
2014 |
50 |
S5 |
p. S238- 1 p. |
artikel |
546 |
997: Non-small cell lung cancer (NSCLC) cancer biomarkers are present in sputum and can be used for diagnosis and therapeutic intervention
|
Jones, D. |
|
2014 |
50 |
S5 |
p. S242- 1 p. |
artikel |
547 |
302: Normal and oncogenic proliferation under control of microRNAs: A functional high content screening
|
Sastre, D. |
|
2014 |
50 |
S5 |
p. S71- 1 p. |
artikel |
548 |
747: Novel anthraquinone-thiosemicarbazones with tautomerizable methylene group as anti-metastatic and anti-angiogenic agents
|
Kolundzija, B. |
|
2014 |
50 |
S5 |
p. S179- 1 p. |
artikel |
549 |
236: Novel approaches for dynamic biomarker imaging by multispectral optoacoustic tomography (MSOT)
|
Driessen, W. |
|
2014 |
50 |
S5 |
p. S55- 1 p. |
artikel |
550 |
155: Novel CSF-1 receptor ligand IL-34 modulates macrophage-breast cancer cell crosstalk
|
Gunawardhana, S. |
|
2014 |
50 |
S5 |
p. S34- 1 p. |
artikel |
551 |
503: Novel FLT3 mutation shows dominant negative effects on the wild-type FLT3 receptor
|
Bauer, J. |
|
2014 |
50 |
S5 |
p. S121- 1 p. |
artikel |
552 |
727: Novel human drug-resistant lymphoblastic cell line exhibits collateral sensitivity to cold stress
|
Cerezo Fernández, D. |
|
2014 |
50 |
S5 |
p. S174- 1 p. |
artikel |
553 |
735: Novel photodynamic therapy with glucose conjugated chlorin for GIST
|
Tanaka, M. |
|
2014 |
50 |
S5 |
p. S176- 1 p. |
artikel |
554 |
68: Novel therapeutic approaches to lung cancer
|
|
|
2014 |
50 |
S5 |
p. S17- 1 p. |
artikel |
555 |
763: Novel therapeutic compounds against human pancreatic cancer cells from wasabi component 6-(methylsulfinyl) hexyl isothiocyanate and derivatives
|
Liao, H.F. |
|
2014 |
50 |
S5 |
p. S183- 1 p. |
artikel |
556 |
496: Nuclear EGFR controls the expression of the ARF tumor suppressor
|
Dayde, D. |
|
2014 |
50 |
S5 |
p. S119- 1 p. |
artikel |
557 |
511: Nuclear PI3K signalling in colorectal cancer
|
Palmieri, M. |
|
2014 |
50 |
S5 |
p. S123- 1 p. |
artikel |
558 |
55: Nuclear RNAi and cell fate
|
|
|
2014 |
50 |
S5 |
p. S14- 1 p. |
artikel |
559 |
729: Nupharidine inhibits NF-kappa B activity, has synergistic cytotoxic activity with cisplatin and etoposide and induces apoptosis
|
Gopas, J. |
|
2014 |
50 |
S5 |
p. S175- 1 p. |
artikel |
560 |
537: Nup155 is linked to the p53 pathway in hepatocellular carcinoma
|
Holzer, K. |
|
2014 |
50 |
S5 |
p. S130- 1 p. |
artikel |
561 |
427: NuRD complex co-operates with PRC2 to suppress gene expression
|
Zhu, W. |
|
2014 |
50 |
S5 |
p. S102-S103 2 p. |
artikel |
562 |
45: OECI Lecture: Cancer genomics and plasma DNA: Towards new classification of breast cancer and monitoring therapy response
|
|
|
2014 |
50 |
S5 |
p. S12- 1 p. |
artikel |
563 |
Official Media Partners
|
|
|
2014 |
50 |
S5 |
p. vi- 1 p. |
artikel |
564 |
81: Oncogenomics of brain tumors: Integrated approaches reveal novel pathomechanisms
|
Lichter, P. |
|
2014 |
50 |
S5 |
p. S20- 1 p. |
artikel |
565 |
330: Only an EpCAM–claudin-7 complex acts as a cancer initiating cell biomarker
|
Thuma, F. |
|
2014 |
50 |
S5 |
p. S78-S79 2 p. |
artikel |
566 |
133: Oral cavity changes in lymphoma patients
|
Besu Zizak, I. |
|
2014 |
50 |
S5 |
p. S30- 1 p. |
artikel |
567 |
43: Outside the coding genome: microRNAs make a big difference
|
He, L. |
|
2014 |
50 |
S5 |
p. S11- 1 p. |
artikel |
568 |
247: Ovarian cancer cells treated with leptin contribute with a pro-tumoral phenotype in macrophages in vitro
|
Abarzua-Catalan, L. |
|
2014 |
50 |
S5 |
p. S58- 1 p. |
artikel |
569 |
619: Overexpression of BMI-1 immortalises normal human urothelial cells
|
Chapman, E.J. |
|
2014 |
50 |
S5 |
p. S147- 1 p. |
artikel |
570 |
674: Oxidized macrophage migration inhibitory factor (oxMIF) occurs specifically in malignant tissue and is a potential new drug target and biomarker in cancer
|
Schinagl, A. |
|
2014 |
50 |
S5 |
p. S163- 1 p. |
artikel |
571 |
558: p53 and other components of the DNA damage response as determinants of cell sensitivity to ATR inhibition
|
Middleton, F.K. |
|
2014 |
50 |
S5 |
p. S134- 1 p. |
artikel |
572 |
838: Panobinostat reduces hypoxia-related cisplatin resistance of non-small cell lung carcinoma cells via HIF-1alpha destabilization
|
Hrzenjak, A. |
|
2014 |
50 |
S5 |
p. S203-S204 2 p. |
artikel |
573 |
327: Paraffin embedded tissue as valuable and challenging resource for studying intratumoral genetic heterogeneity of clear cell renal cell carcinoma
|
Ferronika, P. |
|
2014 |
50 |
S5 |
p. S78- 1 p. |
artikel |
574 |
73: Parainflammation in cancer
|
Lasry, A. |
|
2014 |
50 |
S5 |
p. S18- 1 p. |
artikel |
575 |
741: PARP-inhibitor PJ34 potentiates the anticancer effect of chiral 6,7-bis(hydroxymethyl)-1H,3H-pyrrolo[1,2-c]thiazoles against breast cancer cell lines
|
Santos, K. |
|
2014 |
50 |
S5 |
p. S178- 1 p. |
artikel |
576 |
533: Parthenolide, a NF-úB pathway inhibitor, reduces tumorigenic potential in human colorectal cancer cells
|
Gehren, A.S. |
|
2014 |
50 |
S5 |
p. S129- 1 p. |
artikel |
577 |
647: Partial wave spectroscopic nanocytology to personalize management of early stage prostate cancer
|
Roy, H. |
|
2014 |
50 |
S5 |
p. S154- 1 p. |
artikel |
578 |
702: Pathway analysis of ovarian cancer
|
O’Kane, S.L. |
|
2014 |
50 |
S5 |
p. S169- 1 p. |
artikel |
579 |
225: Patient-derived tissue culture and xenograft models for studying prostate tumor responses to therapy
|
Yu, L. |
|
2014 |
50 |
S5 |
p. S52- 1 p. |
artikel |
580 |
652: Patient-derived xenograft models of acute leukemias for translational research
|
Siegert, A. |
|
2014 |
50 |
S5 |
p. S155-S156 2 p. |
artikel |
581 |
717: PCL-grafted chondroitin sulfate copolymers to promote dualmedicated endocytosis for enhanced anti-cancer drug delivery
|
Wang, L. |
|
2014 |
50 |
S5 |
p. S172-S173 2 p. |
artikel |
582 |
488: PDGFRa-driving mutations found in gastro-intestinal stromal tumors induce receptor mislocalisation and alter the PDGFR-a conventional signalling characteristics
|
Eulenfeld, R. |
|
2014 |
50 |
S5 |
p. S117- 1 p. |
artikel |
583 |
282: p53-directed translational control can shape and expand the universe of p53 target genes
|
Zaccara, S. |
|
2014 |
50 |
S5 |
p. S66-S67 2 p. |
artikel |
584 |
48: Peptide-based immunotherapy of cancer
|
Rammensee, H. |
|
2014 |
50 |
S5 |
p. S12- 1 p. |
artikel |
585 |
892: Peripheral T cell responses in glioblastoma patients are associated with an improved survival
|
Herold-Mende, C. |
|
2014 |
50 |
S5 |
p. S218- 1 p. |
artikel |
586 |
35: Personalised proteotypes and their association with disease
|
Aebersold, R. |
|
2014 |
50 |
S5 |
p. S9-S10 2 p. |
artikel |
587 |
855: Perspectives of hormonal therapy in non-small cell lung cancer (NSCLC) based on estrogen receptor beta expression in tumor tissue
|
Bogush, T.A. |
|
2014 |
50 |
S5 |
p. S208-S209 2 p. |
artikel |
588 |
670: Pharmacokinetic modelling in dynamic contrast enhanced multispectral optoacoustic tomography (DCE-MSOT)
|
Morscher, S. |
|
2014 |
50 |
S5 |
p. S160-S161 2 p. |
artikel |
589 |
704: Phenotype based discovery of novel small molecule anti-angiogenic drugs
|
Butler, C. |
|
2014 |
50 |
S5 |
p. S170- 1 p. |
artikel |
590 |
931: Photodynamic therapy as an option for osteosarcoma
|
Chohfi de Miguel, G. |
|
2014 |
50 |
S5 |
p. S228- 1 p. |
artikel |
591 |
678: Photodynamic therapy effects on tumor vasculature and oxygenation in vivo
|
Krzykawska-Serda, M. |
|
2014 |
50 |
S5 |
p. S163- 1 p. |
artikel |
592 |
810: Photodynamic therapy in non-small cell lung cancer cell line
|
Laranjo, M. |
|
2014 |
50 |
S5 |
p. S196- 1 p. |
artikel |
593 |
830: Phytochemical extract from Senecio graveolens (Chachacoma): Searching new candidates for anti-cancer drugs
|
Echiburú-Chau, C. |
|
2014 |
50 |
S5 |
p. S201- 1 p. |
artikel |
594 |
917: PI3K/Akt and ERK1/2 signaling pathways are involved with the aggressive potential of the progeny derived from radioresistant colorectal cancer cells
|
Marcondes, P.G. |
|
2014 |
50 |
S5 |
p. S224-S225 2 p. |
artikel |
595 |
849: PI3K/mTOR dual inhibition modulates Bcl-2 family proteins expression and sensitizes ovarian carcinoma cells to ABT-737
|
Jebahi, A. |
|
2014 |
50 |
S5 |
p. S207- 1 p. |
artikel |
596 |
192: Pinus morrisonicola Hayata extracts inhibit cell proliferation and promote apoptosis of human promyelocytic HL-60 leukemia cells
|
Liu, G.Y. |
|
2014 |
50 |
S5 |
p. S44- 1 p. |
artikel |
597 |
243: p27 is a haploinsufficient tumor suppressor in MENX rats and this associates with the development of invasive medullary thyroid carcinoma
|
Pellegata, N. |
|
2014 |
50 |
S5 |
p. S57- 1 p. |
artikel |
598 |
890: Plasma levels of cell death biomarker HMGB1 during the first cycle of epirubicin/docetaxel or 5-FU/oxaliplatin
|
Sachet, M. |
|
2014 |
50 |
S5 |
p. S217- 1 p. |
artikel |
599 |
195: Platycodi Radix facilitates autophagy through increasing ROS formation in NCI-H460 human non-small lung carcinoma cells
|
Hong, S.H. |
|
2014 |
50 |
S5 |
p. S44- 1 p. |
artikel |
600 |
716: Plaunotol inhibits doxorubicin-induced renal cell death
|
De-Eknamkul, W. |
|
2014 |
50 |
S5 |
p. S172- 1 p. |
artikel |
601 |
795: Plausible extraction technique for cancer chemopreventive isothiocyanate compounds from the Raphanus sativus L. var. caudatus Alef
|
Sangthong, S. |
|
2014 |
50 |
S5 |
p. S192- 1 p. |
artikel |
602 |
38: Points of interface between autophagy and apoptosis
|
Kimchi, A. |
|
2014 |
50 |
S5 |
p. S10- 1 p. |
artikel |
603 |
379: POLE and POLD1 screening in Portuguese patients with hereditary colorectal cancer
|
Viegas, M. |
|
2014 |
50 |
S5 |
p. S90- 1 p. |
artikel |
604 |
251: Polo-like kinase 4 (plk4) modulates cancer cell polarity and invasion
|
Kazazian, K. |
|
2014 |
50 |
S5 |
p. S59- 1 p. |
artikel |
605 |
122: Poly(I:C) and chemotherapeutics synergistically induce cell death in head and neck cancer cell lines
|
Matijevic Glavan, T. |
|
2014 |
50 |
S5 |
p. S27- 1 p. |
artikel |
606 |
803: Polymeric nanogel delivery system with pH/thermo-responsive doxorubicin release for intracellular drug delivery
|
Chiu, H.C. |
|
2014 |
50 |
S5 |
p. S194- 1 p. |
artikel |
607 |
792: Polysaccharide-based nanocarriers targeting CD44 for lung cancer treatment
|
Jeannot, V. |
|
2014 |
50 |
S5 |
p. S191- 1 p. |
artikel |
608 |
108: Potential effects of telomerase activity and Bcl-2 expression on the apoptosis of the human brain tumors
|
Kim, C. |
|
2014 |
50 |
S5 |
p. S25- 1 p. |
artikel |
609 |
349: Potential interconnection between alternative splicing and microRNA regulation of SRSF1 oncogene in renal cancer
|
Boguslawska, J. |
|
2014 |
50 |
S5 |
p. S83- 1 p. |
artikel |
610 |
963: Potential of tumour-associated autoantibodies as biomarkers for gastric cancer detection
|
Kalnina, Z. |
|
2014 |
50 |
S5 |
p. S235- 1 p. |
artikel |
611 |
466: Potential oncogenic activity of CDK1 gene in laryngeal squamous cell carcinoma
|
Szyfter, K. |
|
2014 |
50 |
S5 |
p. S113- 1 p. |
artikel |
612 |
200: Potential therapeutic targets for the hypoxic niche in glioblastoma
|
Dirkse, A. |
|
2014 |
50 |
S5 |
p. S45- 1 p. |
artikel |
613 |
515: P53 protein evolutionary functional divergence through the lens of a yeast-based transactivation assay
|
Raimondi, I. |
|
2014 |
50 |
S5 |
p. S124- 1 p. |
artikel |
614 |
690: Precision cut cancer tissue slices as a preclinical drug testing platform
|
Unger, F.T. |
|
2014 |
50 |
S5 |
p. S166- 1 p. |
artikel |
615 |
851: Pre-clinical efficacy of the synthetic retinoid ST1926 for treating chronic myeloid leukemia
|
Darwiche, N. |
|
2014 |
50 |
S5 |
p. S207- 1 p. |
artikel |
616 |
296: Preclinical validation of the therapeutic potential of neuropilin-1 targeting transmembrane peptide in glioblastoma
|
Fritz, J. |
|
2014 |
50 |
S5 |
p. S70- 1 p. |
artikel |
617 |
646: Predicting colon cancer occurrence from transcriptomic, splicing and genomic data in colon adenomas
|
Corcos, L. |
|
2014 |
50 |
S5 |
p. S154- 1 p. |
artikel |
618 |
668: Predictive value of Notch associated genes for response and survival in neoadjuvant treated gastric cancer
|
Munzig, A. |
|
2014 |
50 |
S5 |
p. S160- 1 p. |
artikel |
619 |
204: Pre-mRNA alternative splicing controls VEGF-A autocrine functions and response to bevacizumab in non small cell lung carcinoma
|
Boudria, A. |
|
2014 |
50 |
S5 |
p. S46-S47 2 p. |
artikel |
620 |
814: Preparation of micellar oral dosage form of amphotericin B for synergistic enhancement of anti-cancer effects with the pretreatment of ethanolic extract of Taiwanofungus camphoratus
|
Chen, L.C. |
|
2014 |
50 |
S5 |
p. S197- 1 p. |
artikel |
621 |
676: Pretreatment telomere length of peripheral blood neutrophil as a prognostic factor in metastatic non-small cell lung cancer
|
Jang, S.H. |
|
2014 |
50 |
S5 |
p. S162-S163 2 p. |
artikel |
622 |
996: Prevalence of germline MUTYH mutations among Lynch-like syndrome patients
|
Vargas, G. |
|
2014 |
50 |
S5 |
p. S242- 1 p. |
artikel |
623 |
826: Primary T-prolymphocytic leukemia (T-PLL) cells are sensitive to BCL-2 and HDAC inhibitors: Results from high-throughput ex vivo drug testing
|
Andersson, E. |
|
2014 |
50 |
S5 |
p. S200- 1 p. |
artikel |
624 |
259: Procathepsin B and endogenous inhibitors of cysteine proteases as possible biomarkers of ovarian cancer
|
Gashenko, E. |
|
2014 |
50 |
S5 |
p. S61- 1 p. |
artikel |
625 |
389: Process-automation of next generation sequencing for high-throughput mutation analyses in cancer
|
Vollbrecht, C. |
|
2014 |
50 |
S5 |
p. S93- 1 p. |
artikel |
626 |
16: Proffered Paper: Altered mitochondrial function and energy metabolism is associated with a radioresistant phenotype in oesophageal adenocarcinoma
|
Lynam-Lennon, N. |
|
2014 |
50 |
S5 |
p. S5- 1 p. |
artikel |
627 |
28: Proffered Paper: Cancer risk induced by computed tomography scans in pediatrics: first results from a national cohort study in France
|
Journy, N. |
|
2014 |
50 |
S5 |
p. S8- 1 p. |
artikel |
628 |
62: Proffered Paper: Cell-specific proteomic analysis of contact-initiated tumour-endothelial signalling identifies novel regulators of transendothelial migration
|
Locard-Paulet, M. |
|
2014 |
50 |
S5 |
p. S15-S16 2 p. |
artikel |
629 |
78: Proffered Paper: Dual wavelength near-infrared fluorescence imaging of VEGF and IGF-1R in ovarian cancer patient-derived xenografts
|
Tomar, T. |
|
2014 |
50 |
S5 |
p. S19- 1 p. |
artikel |
630 |
54: Proffered Paper: Hypoxic regulation of the long non-coding transcriptome in breast cancer
|
Choudhry, H. |
|
2014 |
50 |
S5 |
p. S14- 1 p. |
artikel |
631 |
70: Proffered Paper: Inhibition of RNA Polymerase I transcription by CX-5461 as a completely new approach to treat highly refractory haematological malignancies
|
Hannan, R. |
|
2014 |
50 |
S5 |
p. S17- 1 p. |
artikel |
632 |
74: Proffered Paper: Investigation of the spatial heterogeneity of specific immune cell phenotypes in the tumor microenvironment of follicular lymphoma
|
Mansfield, J. |
|
2014 |
50 |
S5 |
p. S18-S19 2 p. |
artikel |
633 |
24: Proffered Paper: JAK2/STAT5 inhibition circumvents resistance to PI3K/mTOR blockade: A rationale for co-targeting these pathways in metastatic breast cancer
|
Britschgi, A. |
|
2014 |
50 |
S5 |
p. S7- 1 p. |
artikel |
634 |
40: Proffered Paper: miRNA induces escape from NK cell-mediated cytotoxicity and resistance towards apoptosis in breast cancer
|
Breunig, C. |
|
2014 |
50 |
S5 |
p. S11- 1 p. |
artikel |
635 |
8: Proffered Paper: Mono- and polygenic breast cancer susceptibility associates with error-prone homologous DNA double-strand break repair in mouse and man
|
Wiesmüller, L. |
|
2014 |
50 |
S5 |
p. S3-S4 2 p. |
artikel |
636 |
58: Proffered Paper: Noninvasive monitoring of tumour mutations and dynamics in circulating DNA of non-small cell lung cancer patients treated with EGFR inhibitors
|
Tsui, D. |
|
2014 |
50 |
S5 |
p. S14-S15 2 p. |
artikel |
637 |
50: Proffered Paper: Overcoming immune evasion in ovarian and breast cancer with anti-CD47 antibody blockade: A novel class of immune therapy
|
Volkmer, A.K. |
|
2014 |
50 |
S5 |
p. S13- 1 p. |
artikel |
638 |
36: Proffered Paper: Proteogenomic analysis of human breast cancer connects genetic alterations to phosphorylation networks
|
Mertins, P. |
|
2014 |
50 |
S5 |
p. S10- 1 p. |
artikel |
639 |
66: Proffered Paper: Regulation of NF-kB, inflammation and cancer by the E3 ligase RNF20
|
Tarcic, O. |
|
2014 |
50 |
S5 |
p. S16-S17 2 p. |
artikel |
640 |
20: Proffered Paper: Senescent cells impact premalignant microenvironment by direct protein transfer
|
Biran, A. |
|
2014 |
50 |
S5 |
p. S6- 1 p. |
artikel |
641 |
12: Proffered Paper: The life history of lethal metastatic prostate cancer (The UK prostate cancer working group of the International Cancer Genome Consortium)
|
Wedge, D.C. |
|
2014 |
50 |
S5 |
p. S4- 1 p. |
artikel |
642 |
46: Proffered Paper: Therapeutical landscape of cancer drivers
|
Gonzalez-Perez, A. |
|
2014 |
50 |
S5 |
p. S12- 1 p. |
artikel |
643 |
32: Proffered Paper: Vessel co-option in colorectal cancer liver metastases mediates resistance to conventional anti-angiogenic therapy
|
Thompson, V. |
|
2014 |
50 |
S5 |
p. S9- 1 p. |
artikel |
644 |
386: Profiling of plasma microRNAs in a group of healthy smokers and non-smokers to evaluate their potential as biomarkers of effect following tobacco exposure
|
Banerjee, A. |
|
2014 |
50 |
S5 |
p. S92- 1 p. |
artikel |
645 |
886: Prognostic relevance of tertiary lymphoid organs in oral squamous cell carcinoma
|
Wirsing, A. |
|
2014 |
50 |
S5 |
p. S216- 1 p. |
artikel |
646 |
621: Prognostic significance of neuroendocrine components in gastric carcinomas
|
Kim, H.R. |
|
2014 |
50 |
S5 |
p. S148- 1 p. |
artikel |
647 |
Programme at a Glance
|
|
|
2014 |
50 |
S5 |
p. xxxii-xxxiii nvt p. |
artikel |
648 |
26: Progress in breast cancer prevention
|
Cuzick, J. |
|
2014 |
50 |
S5 |
p. S7- 1 p. |
artikel |
649 |
34: Progress toward a biomarker discovery-to-development pipeline in clinical proteomics
|
Carr, S.A. |
|
2014 |
50 |
S5 |
p. S9- 1 p. |
artikel |
650 |
448: Promoter hypermethylation and overexpression of putative oncomiRs may contribute to silencing of the tumor suppressor gene PCDH17 in laryngeal squamous cell carcinoma
|
Byzia, E. |
|
2014 |
50 |
S5 |
p. S108- 1 p. |
artikel |
651 |
982: Prooxidant activity of resveratrol is associated with higher efficacy in breast cancer prevention
|
Demeckova, V. |
|
2014 |
50 |
S5 |
p. S239- 1 p. |
artikel |
652 |
494: Prostaglandin E2 trans-activates the Colony-Stimulating Factor-1 (CSF-1) receptor and synergizes with CSF-1 in the induction of cell migration in macrophages via the mitogen-activated protein kinase ERK1/2
|
Digiacomo, G. |
|
2014 |
50 |
S5 |
p. S119- 1 p. |
artikel |
653 |
541: Protein complex composition distinguishes different cancer types
|
Ori, A. |
|
2014 |
50 |
S5 |
p. S131- 1 p. |
artikel |
654 |
142: Proteolytic regulation of the EphB4 receptor in prostate cancer
|
Lisle, J. |
|
2014 |
50 |
S5 |
p. S31-S32 2 p. |
artikel |
655 |
981: Proteomic analysis of urinary exosomes in patients with non-small cell lung cancer and tuberculosis pleurisy using SWATH technique
|
Lee, K. |
|
2014 |
50 |
S5 |
p. S239- 1 p. |
artikel |
656 |
533: Proteomic profiling of N-Myc-associated proteins in neuroblastoma
|
Halasz, M. |
|
2014 |
50 |
S5 |
p. S133-S134 2 p. |
artikel |
657 |
901: Psammaplin A (PsA) derivatives inhibit DNA methyltransferase (DNMT) and radiosensitize A549 lung cancer cells
|
Kim, H.J. |
|
2014 |
50 |
S5 |
p. S220- 1 p. |
artikel |
658 |
160: Pterostilbene inhibit hepatocellular carcinoma cells proliferation by induce autophagy and apoptosis in vitro
|
Chiou, H. |
|
2014 |
50 |
S5 |
p. S35- 1 p. |
artikel |
659 |
829: Quality of life, efficacy and tolerability of long term treatment with BP-C1, in patients with stage IV breast cancer
|
Larsen, S. |
|
2014 |
50 |
S5 |
p. S201- 1 p. |
artikel |
660 |
993: Quantification of donor/recipient chimerism in leukemia by digital PCR
|
Hayashibara, K. |
|
2014 |
50 |
S5 |
p. S241-S242 2 p. |
artikel |
661 |
546: Quantitative analysis of autophagic flux in pancreatic ductal adenocarcinoma (PDAC) by cellular heterogeneity measurements
|
Brady, N.R. |
|
2014 |
50 |
S5 |
p. S132- 1 p. |
artikel |
662 |
387: Quantitative analysis of CDKN2A methylation, mRNA, and p16INK4a protein expression in children and adolescents with Burkitt lymphoma: Biological and clinical implications
|
Robaina, M.C. |
|
2014 |
50 |
S5 |
p. S92- 1 p. |
artikel |
663 |
542: Quantitative analysis of NFúB transactivation abilities using a yeast-based in vivo functional assay
|
Sharma, V. |
|
2014 |
50 |
S5 |
p. S131- 1 p. |
artikel |
664 |
777: Quercetin induces mitochondrial-derived apoptosis via reactive oxygen species-mediated ERK activation in acute myeloid leukemia (AML) cells and AML xenograft model
|
Chien, M. |
|
2014 |
50 |
S5 |
p. S187- 1 p. |
artikel |
665 |
393: Rab25 is downregulated and is not associated with invasion in head and neck squamous cell carcinoma
|
Seven, D. |
|
2014 |
50 |
S5 |
p. S93-S94 2 p. |
artikel |
666 |
914: Radiobiological and clinical evaluation results of radiotherapy cancer cervix
|
Turkevich, V. |
|
2014 |
50 |
S5 |
p. S223-S224 2 p. |
artikel |
667 |
249: Radiosensitive and radioresistant colorectal cancer cells
|
Ferreira, A. |
|
2014 |
50 |
S5 |
p. S58-S59 2 p. |
artikel |
668 |
248: Radiotherapy response of breast cancer stem cells
|
Cordeiro, P. |
|
2014 |
50 |
S5 |
p. S58- 1 p. |
artikel |
669 |
970: RAF1 c.*266C>T polymorphism as a protective factor in bladder cancer
|
Ersoy Tunali, N. |
|
2014 |
50 |
S5 |
p. S237- 1 p. |
artikel |
670 |
111: RANK pathway as a new therapeutic target in primary breast cancer
|
Pellegrini, P. |
|
2014 |
50 |
S5 |
p. S25- 1 p. |
artikel |
671 |
525: Reactive oxygen species and nitric oxide in irradiated and irradiation-induced bystander cells
|
Skonieczna, M. |
|
2014 |
50 |
S5 |
p. S127- 1 p. |
artikel |
672 |
657: Real time noninvasive 2D and 3D multispectral optoacoustic tomography (MSOT) for clinical imaging of vessel oxygenation and melanin distribution
|
Burton, N. |
|
2014 |
50 |
S5 |
p. S157- 1 p. |
artikel |
673 |
634: Real-time RT-PCR analysis of galectin-3 expression in fine-needle aspirates of thyroid papillary carcinoma and thyroid non-neoplastic lesions
|
Samija, I. |
|
2014 |
50 |
S5 |
p. S151- 1 p. |
artikel |
674 |
350: Recapitulation of non-small-cell lung carcinoma microenvironment in perfusion bioreactor cultures: the impact of hypoxia on tumour–stroma crosstalk
|
Espírito Santo, V. |
|
2014 |
50 |
S5 |
p. S83- 1 p. |
artikel |
675 |
80: Recent advances in cancer genomics
|
Mardis, E. |
|
2014 |
50 |
S5 |
p. S20- 1 p. |
artikel |
676 |
37: Recent developments in the technology of mass spectrometry-based clinical proteomics
|
Mann, M. |
|
2014 |
50 |
S5 |
p. S10- 1 p. |
artikel |
677 |
630: Receptor tyrosine kinases as novel therapeutic targets in head and neck squamous cell carcinoma
|
Von Mässenhausen, A. |
|
2014 |
50 |
S5 |
p. S150- 1 p. |
artikel |
678 |
583: Recurrent BRCA1/2 mutations in Bulgarian patients with hereditary breast and ovarian cancer
|
Dodova, R. |
|
2014 |
50 |
S5 |
p. S140- 1 p. |
artikel |
679 |
156: Reduced expression of GRHL genes in human non-melanoma skin cancers
|
Kikulska, A. |
|
2014 |
50 |
S5 |
p. S34-S35 2 p. |
artikel |
680 |
360: Reduced promoter methylation and increased expression of CSPG4 negatively influences survival of HNSCC patients
|
Warta, R.W. |
|
2014 |
50 |
S5 |
p. S86- 1 p. |
artikel |
681 |
824: Re-engineering vesicular stomatitis virus to abrogate neurotoxicity, circumvent humoral immunity and enhance oncolytic potency
|
Von Laer, D. |
|
2014 |
50 |
S5 |
p. S199- 1 p. |
artikel |
682 |
648: Regulation of norepinephrine transporter expression in pheochromocytoma by dual PI3K/mTOR inhibition
|
Lee, M. |
|
2014 |
50 |
S5 |
p. S154- 1 p. |
artikel |
683 |
185: Regulation of Panax notoginseng extract on metastasis in human colon cancer cells
|
Wu, C.C. |
|
2014 |
50 |
S5 |
p. S42- 1 p. |
artikel |
684 |
168: Regulation of S-adenosylmethionine synthesis in a sequential model of cirrhosis-hepatocellular cancer by adenosine derivative
|
María Guadalupe, L.R. |
|
2014 |
50 |
S5 |
p. S37-S38 2 p. |
artikel |
685 |
592: Relationship between oxidative DNA damage and p53 mutation in colorectal adenoma and adenocarcinoma
|
Priolli, D.G. |
|
2014 |
50 |
S5 |
p. S143- 1 p. |
artikel |
686 |
506: Relevance of BRAFG615E and BRAFG474R mutations in undifferentiated thyroid carcinomas
|
Muñoz Martinez, R. |
|
2014 |
50 |
S5 |
p. S122- 1 p. |
artikel |
687 |
922: Relevance of 3D-microtissues to investigate the therapeutic oncogenes HER2 and PTK6 in breast cancer
|
Hoefig, I. |
|
2014 |
50 |
S5 |
p. S226- 1 p. |
artikel |
688 |
798: Reovirus infection dysregulates the Ras signaling pathway in canine mast cell tumour cells
|
Hwang, C.C. |
|
2014 |
50 |
S5 |
p. S192-S193 2 p. |
artikel |
689 |
340: Resistin induces a disintegrin and metalloproteinase with thrombospondin motifs-4 gene expression in human chondrosarcoma cell line
|
Hatipoglu, O.F. |
|
2014 |
50 |
S5 |
p. S81- 1 p. |
artikel |
690 |
141: RET/PTC1 in vitro models unveil a novel tumor suppressor miRNA in papillary thyroid carcinoma
|
Minna, E. |
|
2014 |
50 |
S5 |
p. S31- 1 p. |
artikel |
691 |
505: Reverse phase protein array profiling of lobular and triple negative breast cancers within the RATHER consortium
|
De Koning, L. |
|
2014 |
50 |
S5 |
p. S122- 1 p. |
artikel |
692 |
252: RhoGTPase-based regulation of cell spreading by Plk4
|
Brashavitskaya, V. |
|
2014 |
50 |
S5 |
p. S59- 1 p. |
artikel |
693 |
770: Ritonavir interacts with belinostat to cause endoplasmic reticulum stress and histone acetylation synergistically in renal cancer cells
|
Isono, M. |
|
2014 |
50 |
S5 |
p. S185- 1 p. |
artikel |
694 |
15: Role of autophagy in the metabolism and growth of lung cancer
|
White, E. |
|
2014 |
50 |
S5 |
p. S5- 1 p. |
artikel |
695 |
944: Role of BRCA2 in the susceptibility to familial colorectal cancer type X
|
Garre, P. |
|
2014 |
50 |
S5 |
p. S230- 1 p. |
artikel |
696 |
799: Role of cyclosporine A as chemomodulator of cisplatin cytotoxicity in ovarian cancer cell lines
|
Hamilton, G. |
|
2014 |
50 |
S5 |
p. S193- 1 p. |
artikel |
697 |
226: Role of EGFR-regulated microRNAs in malignant processes of non-small cell lung cancer
|
Langsch, S. |
|
2014 |
50 |
S5 |
p. S52- 1 p. |
artikel |
698 |
216: Role of extracellular S100A4 in stimulation of melanoma cells crossing the blood–brain barrier in vitro and in vivo
|
Herwig, N. |
|
2014 |
50 |
S5 |
p. S49- 1 p. |
artikel |
699 |
521: Role of hypoxia and Hypoxia Inducible Factor 1a (HIF1a) in regulation of the HSPA2 gene expression in human keratinocytes
|
Habryka, A. |
|
2014 |
50 |
S5 |
p. S126- 1 p. |
artikel |
700 |
161: Role of Id1–IGF2–VEGF–VEGFR relay in esophageal tumorigenesis
|
Cheung, A.L.M. |
|
2014 |
50 |
S5 |
p. S35-S36 2 p. |
artikel |
701 |
75: Role of inflammation in epidermal carcinogenesis
|
Watt, F.M. |
|
2014 |
50 |
S5 |
p. S19- 1 p. |
artikel |
702 |
516: Role of LPAR3, PKC and EGFR in LPA-induced cell migration in oral squamous carcinoma cells
|
Brusevold, I. |
|
2014 |
50 |
S5 |
p. S124- 1 p. |
artikel |
703 |
173: Role of NANOS family members in tumor progression
|
De Keuckelaere, E. |
|
2014 |
50 |
S5 |
p. S39- 1 p. |
artikel |
704 |
254: Role of prominin-1 (CD133)-exosomes released by melanoma cells in intercellular communication
|
Lorico, A. |
|
2014 |
50 |
S5 |
p. S60- 1 p. |
artikel |
705 |
574: Role of prostate apoptosis response-4 in ovarian cancer cells
|
Meynier, S. |
|
2014 |
50 |
S5 |
p. S138- 1 p. |
artikel |
706 |
354: Role of the gluconeogenic enzyme phosphoenolpyruvate carboxykinase in lung cancer
|
Leithner, K. |
|
2014 |
50 |
S5 |
p. S84- 1 p. |
artikel |
707 |
61: Role of the Hippo transducers YAP and TAZ in mechanotransduction and cancer stem cells
|
Piccolo, S. |
|
2014 |
50 |
S5 |
p. S15- 1 p. |
artikel |
708 |
359: Role of the polarity protein Par3 in promotion and suppression of skin tumors
|
Kleefisch, D. |
|
2014 |
50 |
S5 |
p. S85-S86 2 p. |
artikel |
709 |
64: Role of TP53 and other tumour suppressors in breast cancer development and progression
|
Børresen-Dale, A. |
|
2014 |
50 |
S5 |
p. S16- 1 p. |
artikel |
710 |
167: Role of trefoil factor-3 peptide (TFF3) in prostate cancer progression
|
Nowak, M. |
|
2014 |
50 |
S5 |
p. S37- 1 p. |
artikel |
711 |
184: Roles of digoxin and digitoxin in hepatocellular carcinoma
|
Huang, W. |
|
2014 |
50 |
S5 |
p. S42- 1 p. |
artikel |
712 |
425: RUNX1 structural variants in oesophageal adenocarcinoma
|
Hsu, R.C.J. |
|
2014 |
50 |
S5 |
p. S102- 1 p. |
artikel |
713 |
809: Salivary exosomes of oral cancer patients may serve as a diagnostic tool since they differ from those found in the saliva of healthy individuals
|
Zlotogorski-Hurvitz, A. |
|
2014 |
50 |
S5 |
p. S195-S196 2 p. |
artikel |
714 |
Satellite Symposia
|
|
|
2014 |
50 |
S5 |
p. xxix-xxx nvt p. |
artikel |
715 |
Scientific Programme
|
|
|
2014 |
50 |
S5 |
p. xxxiv-lxxxiv nvt p. |
artikel |
716 |
866: Screening of Lactobacillus reuteri strains for their short chain fatty acids production, stability and potential in colorectal cancer: In-vitro analysis
|
Kahouli, I. |
|
2014 |
50 |
S5 |
p. S212- 1 p. |
artikel |
717 |
60: Selection and adaptation during metastatic cancer progression
|
Klein, C. |
|
2014 |
50 |
S5 |
p. S15- 1 p. |
artikel |
718 |
129: Semaphorin7A increases growth and metastasis of mammary tumours by promoting tumour cell survival and motility
|
Garcia-Areas, R. |
|
2014 |
50 |
S5 |
p. S28-S29 2 p. |
artikel |
719 |
580: Sensitive detection of NRAS mutations using mutant-enriched PCR and reverse-hybridization teststrips
|
Novy, M. |
|
2014 |
50 |
S5 |
p. S139-S140 2 p. |
artikel |
720 |
237: Sequential application of targeted therapies guided by biomarkers overcomes therapy resistance in rapidly evolving highly aggressive mammary tumors
|
Sahin, O. |
|
2014 |
50 |
S5 |
p. S55- 1 p. |
artikel |
721 |
691: SERPINE1 immunostaining is associated with clinical outcome in head and neck squamous cell carcinoma
|
Téllez-Gabriel, M. |
|
2014 |
50 |
S5 |
p. S166- 1 p. |
artikel |
722 |
883: Serum-dependent processing of late apoptotic cells for enhanced efferocytosis
|
Liang, Y. |
|
2014 |
50 |
S5 |
p. S215-S216 2 p. |
artikel |
723 |
172: Serum endostatin levels are elevated in colorectal cancer and correlate with invasion and systemic inflammatory markers
|
Tuomisto, A. |
|
2014 |
50 |
S5 |
p. S38-S39 2 p. |
artikel |
724 |
705: Shifts in mitochondrial energy metabolism are correlated with disease progression in Barrett’s oesophagus
|
Phelan, J. |
|
2014 |
50 |
S5 |
p. S170- 1 p. |
artikel |
725 |
667: Shorter multimarker signatures: a new tool to facilitate cancer diagnosis
|
Guergova-Kuras, M. |
|
2014 |
50 |
S5 |
p. S160- 1 p. |
artikel |
726 |
697: Significance of NF-kB2 genetic variations rs7897947, rs11574852 and rs12769316 in non-small-cell lung cancer: a case–control study
|
Dimitrakopoulos, F. |
|
2014 |
50 |
S5 |
p. S168- 1 p. |
artikel |
727 |
280: Silencing of mitochondrial Lon protease deeply alters mitochondrial proteome and functionality in RKO colorectal carcinoma cells
|
Gibellini, L. |
|
2014 |
50 |
S5 |
p. S66- 1 p. |
artikel |
728 |
323: Simplifying high throughput 3D tumour spheroid growth and shrinkage assays using live content imaging
|
Dale, T. |
|
2014 |
50 |
S5 |
p. S77- 1 p. |
artikel |
729 |
202: Simultaneous measurements of multiple injected contrast agents using multispectral optoacoustic tomography (MSOT) in phantoms and in vivo
|
Sardella, T. |
|
2014 |
50 |
S5 |
p. S46- 1 p. |
artikel |
730 |
858: Simvastatin modifies the expression of stemness and epithelial–mesenchymal transition (EMT) markers in ovarian cancer-initiating cells resulting in decreased cell migration
|
Kato, S. |
|
2014 |
50 |
S5 |
p. S209-S210 2 p. |
artikel |
731 |
903: Single-fraction of gamma radiation induces apoptosis in cultured HeLa cervical cancer cells
|
Khalilia, W. |
|
2014 |
50 |
S5 |
p. S221- 1 p. |
artikel |
732 |
341: SLC22A18, a solute carrier transporter, acts on a tumor suppressor in colorectal cancer via KRAS
|
Jung, Y. |
|
2014 |
50 |
S5 |
p. S81- 1 p. |
artikel |
733 |
338: Smad ubiquitination regulatory factor 2 (Smurf2) regulates the gap junction protein connexin43 during mitosis
|
Fykerud, T.A. |
|
2014 |
50 |
S5 |
p. S80- 1 p. |
artikel |
734 |
535: Small RNA sequencing identifies microRNAs involved in B-cell receptor signaling in chronic lymphocytic leukemia
|
Blume, C.J. |
|
2014 |
50 |
S5 |
p. S129- 1 p. |
artikel |
735 |
659: Somatic mutation profiles in primary colorectal cancers and matching ovarian metastases: Identification of driver and passenger mutations
|
Crobach, S. |
|
2014 |
50 |
S5 |
p. S157-S158 2 p. |
artikel |
736 |
736: Sorafenib and 18F-fluorocholine: New options in cholangiocarcinoma therapy and diagnosis?
|
Brito, A. |
|
2014 |
50 |
S5 |
p. S176- 1 p. |
artikel |
737 |
240: SOX14 downregulates SOX1 expression in HeLa cells
|
Petrovic, I. |
|
2014 |
50 |
S5 |
p. S56- 1 p. |
artikel |
738 |
591: S100P, a calcium-binding protein, is associated with polypoid tumour growth in colorectal carcinogenesis
|
Chiang, J. |
|
2014 |
50 |
S5 |
p. S143- 1 p. |
artikel |
739 |
162: Specific EMT-inducers signature associates with oncogenic events in breast tumour progression
|
Moyret-Lalle, C. |
|
2014 |
50 |
S5 |
p. S36- 1 p. |
artikel |
740 |
41: Sphingomyelin metabolism as a target for cancer therapy
|
Jäättelä, M. |
|
2014 |
50 |
S5 |
p. S11- 1 p. |
artikel |
741 |
337: STAT3, IL-17 and COX-2 features in the transgenic adenocarcinoma of mouse prostate (TRAMP) model and in the aging mice (FVB) submitted to goniothalamin therapy
|
Kido, L.A. |
|
2014 |
50 |
S5 |
p. S80- 1 p. |
artikel |
742 |
262: STAT3-induced WDR1 expression is associated with breast cancer cell migration
|
Lee, J.H. |
|
2014 |
50 |
S5 |
p. S61- 1 p. |
artikel |
743 |
332: Stem cell fractions of extra- and intrahepatic cholangiocellular carcinoma cell lines differ in size and phenotype
|
Schmuck, R. |
|
2014 |
50 |
S5 |
p. S79- 1 p. |
artikel |
744 |
85: Stem cells in homeostasis and cancer
|
Fuchs, E. |
|
2014 |
50 |
S5 |
p. S21-S22 2 p. |
artikel |
745 |
258: Stimulated prostatic angiogenesis in senescence resembles the microenvironment of neoplastic lesions and can be reversed by antiangiogenic therapy
|
Montico, F. |
|
2014 |
50 |
S5 |
p. S60-S61 2 p. |
artikel |
746 |
731: Studies on the modulation of cisplatin activity in NSCLC by KRAS: Role of specific mutations at codon 12
|
Caiola, E. |
|
2014 |
50 |
S5 |
p. S175-S176 2 p. |
artikel |
747 |
579: Subtype specific expression of HRH1 contributes to increased chemoresistance of breast cancer
|
Mancino, M. |
|
2014 |
50 |
S5 |
p. S139- 1 p. |
artikel |
748 |
859: Survey of activated kinase proteins reveals PI3K/Akt and Wnt/β-catenin signaling pathways as potential targets for cholangiocarcinoma treatment
|
Loilome, W. |
|
2014 |
50 |
S5 |
p. S210- 1 p. |
artikel |
749 |
Susan G. Komen
|
|
|
2014 |
50 |
S5 |
p. xx- 1 p. |
artikel |
750 |
101: SWAP-70 is required for spontaneous transformation of mouse embryo fibroblasts
|
Chang, Y.T. |
|
2014 |
50 |
S5 |
p. S23- 1 p. |
artikel |
751 |
682: Synergistic combination of valproic acid and oncolytic parvovirus H-1PV as a potential therapy against cervical and pancreatic carcinomas
|
Li, J. |
|
2014 |
50 |
S5 |
p. S164- 1 p. |
artikel |
752 |
775: Synergistic targeting to HER2-positive breast cancer via nanocapsules with tunable ligand density and magnetic targeting
|
Chiang, C. |
|
2014 |
50 |
S5 |
p. S186- 1 p. |
artikel |
753 |
812: Systematic investigation of drug resistance factors in colorectal cancer cells using pooled CRISPR/Cas9 knockout screens
|
Zhan, T. |
|
2014 |
50 |
S5 |
p. S196-S197 2 p. |
artikel |
754 |
842: Systematic phenotypic profiling of chemical-genetic interactions in human cancer cells
|
Breinig, M. |
|
2014 |
50 |
S5 |
p. S205- 1 p. |
artikel |
755 |
196: System-wide characterization of dynamics of cytosolic macromolecular protein complexes during oncogene-induced cell transformation
|
Diedrich, B. |
|
2014 |
50 |
S5 |
p. S44-S45 2 p. |
artikel |
756 |
632: Tamoxifen resistance can be overcome by salinomycin treatment
|
Sommer, A. |
|
2014 |
50 |
S5 |
p. S151- 1 p. |
artikel |
757 |
71: Targeted cancer genetics
|
Von Kalle, C. |
|
2014 |
50 |
S5 |
p. S17-S18 2 p. |
artikel |
758 |
429: Targeted next-generation sequencing - Identification of Lynch syndrome cases
|
Talseth-Palmer, B.A. |
|
2014 |
50 |
S5 |
p. S103- 1 p. |
artikel |
759 |
357: Targeted therapy makes EGFR promiscuous: EGFR and c-Met interaction in lung cancer
|
Ortiz-Zapater, E. |
|
2014 |
50 |
S5 |
p. S85- 1 p. |
artikel |
760 |
33: Targeting cancer-related inflammation
|
Balkwill, F. |
|
2014 |
50 |
S5 |
p. S9- 1 p. |
artikel |
761 |
749: Targeting cell-surface nucleolin in metastatic breast cancer
|
Gregório, A. |
|
2014 |
50 |
S5 |
p. S180- 1 p. |
artikel |
762 |
6: Targeting MTH1 prevents sanitation of oxidised dNTP pools and causes cancer-selective DNA damage and cell death
|
Helleday, T. |
|
2014 |
50 |
S5 |
p. S3- 1 p. |
artikel |
763 |
771: Targeting MYC-driven growth and proliferation in prostate cancer
|
Rebello, R. |
|
2014 |
50 |
S5 |
p. S185- 1 p. |
artikel |
764 |
600: Targeting nucleolin in lung cancer - an emerging strategy to overcome stroma-mediated anti-VEGF resistance
|
Valério-Fernandes, A. |
|
2014 |
50 |
S5 |
p. S145- 1 p. |
artikel |
765 |
861: Targeting the HSF1/HSP70/BAG3 pathway for reactivation of apoptosis in glioma
|
Koegel, D. |
|
2014 |
50 |
S5 |
p. S210- 1 p. |
artikel |
766 |
984: Tartrate-resistant acid phosphatase role in the diagnosis of metastatic bone lesions
|
Protsenko, V. |
|
2014 |
50 |
S5 |
p. S240- 1 p. |
artikel |
767 |
557: Telomerase inhibition decreases alpha-fetoprotein expression in hepatocellular carcinoma cells in vitro and in vivo: Possible involvement of interleukin-6 induced PI3K/Akt/mTor pathway
|
Tahtouh, R. |
|
2014 |
50 |
S5 |
p. S134- 1 p. |
artikel |
768 |
415: Telomerase reverse transcriptase promoter mutations in primary cutaneous melanoma
|
Heidenreich, B. |
|
2014 |
50 |
S5 |
p. S99- 1 p. |
artikel |
769 |
640: Telomere length and DAPK1 expression: prognosis implication in non-small cell lung cancer
|
Fernández-Marcelo, T. |
|
2014 |
50 |
S5 |
p. S152- 1 p. |
artikel |
770 |
605: Testing cancer related gene panels for high throughput parallel sequencing
|
Vollbrecht, C. |
|
2014 |
50 |
S5 |
p. S145-S146 2 p. |
artikel |
771 |
424: TET2 gene expression and 5-hydroxymethylcytosine levels are decreased in pediatric patients with myelodysplastic syndrome
|
Coutinho, D. |
|
2014 |
50 |
S5 |
p. S101-S102 2 p. |
artikel |
772 |
197: Tetraarsenic hexaoxide induces apoptosis in human bladder cancer 5637 cells via reactive oxygen species generation and DNA damage
|
Han, M.H. |
|
2014 |
50 |
S5 |
p. S45- 1 p. |
artikel |
773 |
193: Tetraindole suppresses breast cancer growth and metastasis by reversing epithelial–mesenchymal transition state associated with up-regulation of the miR-200 family
|
Li, W. |
|
2014 |
50 |
S5 |
p. S44- 1 p. |
artikel |
774 |
413: TET1 was an important factor for DNA demethylation to regulate the expression of MUC1 and MUC4 in lung cancer
|
Yokoyama, S. |
|
2014 |
50 |
S5 |
p. S98-S99 2 p. |
artikel |
775 |
201: The aging suppressor hormone klotho: A novel tumor suppressor and regulator of estrogen signaling in ovarian cancer
|
Lojkin, I. |
|
2014 |
50 |
S5 |
p. S45-S46 2 p. |
artikel |
776 |
701: The alternative pathway of NF-kB is deregulated in NSCLC?
|
Dimitrakopoulos, F.I. |
|
2014 |
50 |
S5 |
p. S169- 1 p. |
artikel |
777 |
186: The anti-cancer effects of clioquinol on oral cancer
|
Lee, M.W. |
|
2014 |
50 |
S5 |
p. S42- 1 p. |
artikel |
778 |
828: The anti-tumor activity of simvastatin encapsulated in long circulating liposomes is dependent on the intratumoral macrophages
|
Licarete, E. |
|
2014 |
50 |
S5 |
p. S200-S201 2 p. |
artikel |
779 |
850: The antitumor agent obatoclax displays antimetastatic properties on melanoma cells in vitro and in vivo
|
Soto-Cerrato, V. |
|
2014 |
50 |
S5 |
p. S207- 1 p. |
artikel |
780 |
381: The ApcMin/+ mouse to identify “driver” epigenetic lesions in colorectal cancer: promoter hypermethylation of the protocadherins
|
Williams, M. |
|
2014 |
50 |
S5 |
p. S91- 1 p. |
artikel |
781 |
9: The ATM-mediated DNA damage response: Implications for cancer development and treatment
|
Shiloh, Y. |
|
2014 |
50 |
S5 |
p. S4- 1 p. |
artikel |
782 |
44: The benefits of precision medicine will require us to examine both what we do and how we do it
|
Friend, S. |
|
2014 |
50 |
S5 |
p. S12- 1 p. |
artikel |
783 |
3: The cancer epigenome
|
Jones, P. |
|
2014 |
50 |
S5 |
p. S1- 1 p. |
artikel |
784 |
848: The characterization of ascorbic acid loaded solid lipid nanoparticles
|
Dikmen, G. |
|
2014 |
50 |
S5 |
p. S206-S207 2 p. |
artikel |
785 |
837: The combination of retinoic acid and protein kinase C modulators as a novel therapy for the growth inhibition of cancer stem cells in a triple negative murine mammary cancer model
|
Berardi, D. |
|
2014 |
50 |
S5 |
p. S203- 1 p. |
artikel |
786 |
450: The consequence of SETD2 mutation in clear cell renal cell carcinoma progenitor cells
|
Li, J. |
|
2014 |
50 |
S5 |
p. S109- 1 p. |
artikel |
787 |
214: The deubiquitinating enzyme USP15 deubiquitinates the E3 ligase SMURF2
|
Iyengar, P. |
|
2014 |
50 |
S5 |
p. S49- 1 p. |
artikel |
788 |
213: The direct cytotoxic and P-glycoprotein modulating effects of Thai indigenous plant extracts in drug resistant HepG2 cells
|
Junhom, C. |
|
2014 |
50 |
S5 |
p. S49- 1 p. |
artikel |
789 |
445: The DNA demethylating agent zebularine inhibits medulloblastoma growth in vitro in association with the regulation of cell cycle and apoptosis-related genes
|
Andrade, A.F. |
|
2014 |
50 |
S5 |
p. S107- 1 p. |
artikel |
790 |
833: The effect of fibroblast growth factor receptor inhibition on the growth of breast cancer cells
|
Khäkönen, T.E. |
|
2014 |
50 |
S5 |
p. S202- 1 p. |
artikel |
791 |
800: The effect of 50% hydroethanolic extract of Pinus kesiya on apoptosis in hepatocellular carcinoma (HepG2) cells
|
Nonpanya, A. |
|
2014 |
50 |
S5 |
p. S193- 1 p. |
artikel |
792 |
265: The effects of INhibitor of Growth 3 (ING3) on prostate cancer cell survival and invasion
|
Nabbi, A. |
|
2014 |
50 |
S5 |
p. S62- 1 p. |
artikel |
793 |
758: The effects on apoptotic and autophagic cell death pathways of endemic Colchicum baytopiorum C.D. Brickell extract in HeLa cells
|
Dagdeviren, O. |
|
2014 |
50 |
S5 |
p. S182- 1 p. |
artikel |
794 |
203: The ethanolic extract of Phellinus linteus inhibits breast cancer cell growth through autophagy-related cell death
|
Lee, W. |
|
2014 |
50 |
S5 |
p. S46- 1 p. |
artikel |
795 |
564: The expression level of MACC1 in early stage CRC patients of Turkish population
|
Ceylan, S. |
|
2014 |
50 |
S5 |
p. S135- 1 p. |
artikel |
796 |
187: The expression of the human Sprouty protein-1 (hSpry1) inversely correlates with proliferation, migration and invasion of the SKOV-3 and 1A9 human ovarian cancer cells
|
Masoumi-Moghaddam, S. |
|
2014 |
50 |
S5 |
p. S42- 1 p. |
artikel |
797 |
232: The glycolytic enzyme GPI/AMF is a stimulator of glioma cell migration and directly contributes to the pro-migratory phenotype under hypoxic conditions
|
Kathagen, A. |
|
2014 |
50 |
S5 |
p. S54- 1 p. |
artikel |
798 |
796: The G-quadruplex ligand EMICORON has antitumoral activity against orthotopic and patient-derived human colon cancer xenografts
|
Porru, M. |
|
2014 |
50 |
S5 |
p. S192- 1 p. |
artikel |
799 |
571: The Hippo pathway gene, YAP, is an oncogene in ovarian cancer
|
Zhang, X. |
|
2014 |
50 |
S5 |
p. S137- 1 p. |
artikel |
800 |
822: The histone acetyltransferases inhibitor CPTH6 preferentially inhibits proliferation of patient-derived lung cancer stem cells in vitro and in vivo
|
Di Martile, M. |
|
2014 |
50 |
S5 |
p. S199- 1 p. |
artikel |
801 |
217: The identification of novel targets in β-catenin-driven acute myeloid leukemic stem cells
|
Yi, H. |
|
2014 |
50 |
S5 |
p. S50- 1 p. |
artikel |
802 |
979: The immunomodulating and anti-inflammatory effects of garlic organosulfur compounds in cancer prevention
|
Hitchcock, J. |
|
2014 |
50 |
S5 |
p. S238-S239 2 p. |
artikel |
803 |
567: The impact of chronic cisplatin treatment on DNA repair in head and neck squamous cell carcinoma
|
Su, W. |
|
2014 |
50 |
S5 |
p. S136- 1 p. |
artikel |
804 |
581: The influence of pre- and postharvest treatments on selected biological and epigenetic activities of Brassica sprouts
|
Kolodziejski, D. |
|
2014 |
50 |
S5 |
p. S140- 1 p. |
artikel |
805 |
363: The ING1 tumour suppressor induces senescence via altering endocytosis
|
Riabowol, K. |
|
2014 |
50 |
S5 |
p. S86-S87 2 p. |
artikel |
806 |
365: The interplay between the redox environment, MTH1 and cancer
|
Braeutigam, L. |
|
2014 |
50 |
S5 |
p. S87- 1 p. |
artikel |
807 |
278: The kallikrein-related serine peptidase, KLK4, regulates the TGFb1 pathway in the tumour–stroma microenvironment in prostate cancer
|
Clements, J. |
|
2014 |
50 |
S5 |
p. S65-S66 2 p. |
artikel |
808 |
229: The LIM domain protein cysteine-rich protein 2 (CRP2) promotes breast cancer progression
|
Hoffmann, C. |
|
2014 |
50 |
S5 |
p. S53- 1 p. |
artikel |
809 |
297: The metabolic cooperation between prostate carcinoma cells and cancer associated fibroblasts: pyruvate kinase M2 at the crossroads
|
Giannoni, E. |
|
2014 |
50 |
S5 |
p. S70- 1 p. |
artikel |
810 |
595: The miR21/10b ratio as a prognostic marker in metastasis-free clear cell renal cell carcinoma patients
|
Fritz, H. |
|
2014 |
50 |
S5 |
p. S143-S144 2 p. |
artikel |
811 |
786: The mitogen-activated protein kinase ERK5 regulates the development and growth of hepatocellular carcinoma
|
Rovida, E. |
|
2014 |
50 |
S5 |
p. S189- 1 p. |
artikel |
812 |
116: The mRNA-binding protein LARP1 is a pro-survival factor that promotes tumourigenicity and chemotherapy resistance in ovarian cancer
|
Hopkins, T.G. |
|
2014 |
50 |
S5 |
p. S26- 1 p. |
artikel |
813 |
42: The mutant p53-cancer stem cells and drug resistance paradigm
|
Rotter, V. |
|
2014 |
50 |
S5 |
p. S11- 1 p. |
artikel |
814 |
56: The NCI early detection research network: Charting the course of biomarker research
|
Srivastava, S. |
|
2014 |
50 |
S5 |
p. S14- 1 p. |
artikel |
815 |
611: The new orthotopic locally advanced animal model of prostate cancer
|
Tavares-Silva, E. |
|
2014 |
50 |
S5 |
p. S147- 1 p. |
artikel |
816 |
310: The novel use of BAMLET in the treatment of oral squamous cell carcinoma
|
Sinevici, N. |
|
2014 |
50 |
S5 |
p. S74- 1 p. |
artikel |
817 |
575: The oncogenic potential of TWIST1 is specifically assigned to the TWIST1-E2A complex
|
Jacqueroud, L. |
|
2014 |
50 |
S5 |
p. S138- 1 p. |
artikel |
818 |
637: The PATH biobank: German breast cancer patients approve of genome wide association studies
|
Mayer, C. |
|
2014 |
50 |
S5 |
p. S151-S152 2 p. |
artikel |
819 |
712: The pig as a model for human cancer
|
Saalfrank, A. |
|
2014 |
50 |
S5 |
p. S172- 1 p. |
artikel |
820 |
808: The PI3K/mTOR inhibitor NVP-BEZ235 is able to revert selumetinib resistance in colorectal cancer cellular models
|
Martinez-Lacaci, I. |
|
2014 |
50 |
S5 |
p. S195- 1 p. |
artikel |
821 |
951: The polymorphism in C677T methylenetetrahydrofolate reductase, and the risk of colorectal cancer in the Moroccan population
|
Azzam, F. |
|
2014 |
50 |
S5 |
p. S232- 1 p. |
artikel |
822 |
107: The positive feedback between interleukin-8 (IL-8) and matrix metalloproteinase-9 (MMP-9) in hormone dependent breast cancer
|
Milovanovic, J. |
|
2014 |
50 |
S5 |
p. S24-S25 2 p. |
artikel |
823 |
482: The p53-Rbm38 loop and its role in tumor suppression and premature aging
|
Chen, X. |
|
2014 |
50 |
S5 |
p. S116- 1 p. |
artikel |
824 |
501: The prognostic value of β-catenin in anal cancer
|
Jacob, H. |
|
2014 |
50 |
S5 |
p. S121- 1 p. |
artikel |
825 |
361: The putative tumor suppressor gene Dickkopf-3 (DKK3) and its role in the carcinogenesis of breast cancer
|
Lorsy, E. |
|
2014 |
50 |
S5 |
p. S86- 1 p. |
artikel |
826 |
675: Therapeutic and diagnostic targeting of gastrointestinal tumors with Shiga Toxin B subunit
|
Maak, M. |
|
2014 |
50 |
S5 |
p. S163- 1 p. |
artikel |
827 |
865: Therapeutic response of modified rutin (Q3G) in animal model of human adenocarcinoma colon
|
Castilho, D. |
|
2014 |
50 |
S5 |
p. S211-S212 2 p. |
artikel |
828 |
706: The relevance of Epstein–Barr virus (EBV) DNA load and the oncogenic protein BARF1, as response and therapeutic monitoring predictive factors in undifferentiated nasopharyngeal carcinoma (UNPC) – The VEBINASO study
|
Costa, D. |
|
2014 |
50 |
S5 |
p. S170- 1 p. |
artikel |
829 |
479: The role of Breast Cancer Associated gene 2 in EGFR endocytosis, downregulation and breast cancer survival
|
Wymant, J. |
|
2014 |
50 |
S5 |
p. S115- 1 p. |
artikel |
830 |
134: The role of Delta-40p53 and p53 in Estrogen Receptor-a signalling pathways in breast cancer
|
Morten, B. |
|
2014 |
50 |
S5 |
p. S30- 1 p. |
artikel |
831 |
499: The role of Hedgehog signaling pathway in the regulation of SOX18 gene expression in cervical carcinoma cell line
|
Petrovic, I. |
|
2014 |
50 |
S5 |
p. S120- 1 p. |
artikel |
832 |
385: The role of miR-375 in prostate carcinogenesis
|
Costa-Pinheiro, P. |
|
2014 |
50 |
S5 |
p. S92- 1 p. |
artikel |
833 |
455: The role of new cancer hallmarks in tumorigenesis
|
Gonzalez-Perez, A. |
|
2014 |
50 |
S5 |
p. S110- 1 p. |
artikel |
834 |
384: The role of ODZ4 in epithelial cancers
|
Mirza, T. |
|
2014 |
50 |
S5 |
p. S91-S92 2 p. |
artikel |
835 |
568: The role of Slit1 in angiogenesis
|
Pan, K.F. |
|
2014 |
50 |
S5 |
p. S136- 1 p. |
artikel |
836 |
115: The role of sumoylation in the regulation of p53 response
|
Marouco, D. |
|
2014 |
50 |
S5 |
p. S26- 1 p. |
artikel |
837 |
534: The role of the cell adhesion molecule E-cadherin in cetuximab sensitivity of gastric cancer cell lines
|
Keller, S. |
|
2014 |
50 |
S5 |
p. S129- 1 p. |
artikel |
838 |
165: The role of the transcription factor ecotropic viral integration site 1 in prostate cancer
|
Queisser, A. |
|
2014 |
50 |
S5 |
p. S37- 1 p. |
artikel |
839 |
366: The role of tumour derived extracellular matrices on macrophage polarization
|
Pinto, M.L. |
|
2014 |
50 |
S5 |
p. S87- 1 p. |
artikel |
840 |
218: The role of WWOX gene in EMT process in endometrial cancer
|
Pluciennik, E. |
|
2014 |
50 |
S5 |
p. S50- 1 p. |
artikel |
841 |
475: The role of ZEB2-induced epithelial–mesenchymal transition in DNA repair
|
Tse, G.C. |
|
2014 |
50 |
S5 |
p. S114-S115 2 p. |
artikel |
842 |
845: The ROS/SUMO axis is involved in acute myeloid leukemia (AML) cells response to chemotherapeutic drugs and constitutes a potential target to overcome chemoresistance in AML
|
Piechaczyk, M. |
|
2014 |
50 |
S5 |
p. S205-S206 2 p. |
artikel |
843 |
585: The synthetic Tryptanthrin analogue suppresses STATs signalling and induces caspase dependent apoptosis via ERK up regulation in human leukemia HL-60 cells
|
Pathania, A. |
|
2014 |
50 |
S5 |
p. S141- 1 p. |
artikel |
844 |
351: The TALE homeodomain transcription factor MEIS1 activates the pro-metastatic melanoma cell adhesion molecule Mcam to promote migration of pancreatic cancer cells
|
Von Burstin, J. |
|
2014 |
50 |
S5 |
p. S84- 1 p. |
artikel |
845 |
221: The T-box transcription factor, TBX3, promotes tumourigenesis in soft tissue and bone sarcomas: a possible therapeutic target
|
Willmer, T. |
|
2014 |
50 |
S5 |
p. S51- 1 p. |
artikel |
846 |
69: The TGF-beta pathway as a therapeutic target
|
Seoane, J. |
|
2014 |
50 |
S5 |
p. S17- 1 p. |
artikel |
847 |
669: The transcription factor Phox2a plays a pro-tumorigenic role in pheochromocytoma
|
Leinhäuser, I. |
|
2014 |
50 |
S5 |
p. S160- 1 p. |
artikel |
848 |
507: The tumour-promoting receptor tyrosine kinase, EphB4, regulates expression of integrin b8 in prostate cancer cells
|
Herington, A. |
|
2014 |
50 |
S5 |
p. S122-S123 2 p. |
artikel |
849 |
103: The tumour–stroma niche of ovarian cancer in 3D
|
Loessner, D. |
|
2014 |
50 |
S5 |
p. S24- 1 p. |
artikel |
850 |
291: The 5′-untranslated region of p16INK4a acts as a cellular IRES, controls mRNA translation during hypoxic and energetic stresses, and is a target of YBX1
|
Bisio, A. |
|
2014 |
50 |
S5 |
p. S69- 1 p. |
artikel |
851 |
227: The WWOX gene modulates the adhesion of neural cells to ECM
|
Kosla, K. |
|
2014 |
50 |
S5 |
p. S52- 1 p. |
artikel |
852 |
405: Tolerance to mitotic defects contributes to chromosomal instability in post-tetraploid progeny
|
Kuznetsova, A. |
|
2014 |
50 |
S5 |
p. S96-S97 2 p. |
artikel |
853 |
270: TPRG1L is a novel microRNA-21 target: a possible linkage between miR-21 and cellular senescence in liver fluke-associated cholangiocarcinoma
|
Chusorn, P. |
|
2014 |
50 |
S5 |
p. S63-S64 2 p. |
artikel |
854 |
409: Transcription factors with differential transcription start sites during B-cell differentiation in normal tissues and diffuse large B-cell lymphoma
|
Bødker, J. |
|
2014 |
50 |
S5 |
p. S97-S98 2 p. |
artikel |
855 |
869: Transcriptome and pathway analysis identifies IRF1 as a predictor of progression free and overall survival in ovarian carcinoma
|
Billaud, J. |
|
2014 |
50 |
S5 |
p. S213- 1 p. |
artikel |
856 |
781: Transfection of chitosan/KillerRed/gPGA complex to intrinsically generate photosensitizer for photodynamic therapy
|
Huang, C.C. |
|
2014 |
50 |
S5 |
p. S188- 1 p. |
artikel |
857 |
787: Transferrin-conjugated self assembled nanoparticles incorporating ZOL as a tool for the targeting of glioblastoma
|
Caraglia, M. |
|
2014 |
50 |
S5 |
p. S189- 1 p. |
artikel |
858 |
643: Transglutaminase 2, a potential biomarker and therapeutic target for meningioma by microarray analysis
|
Huang, Y.C. |
|
2014 |
50 |
S5 |
p. S153- 1 p. |
artikel |
859 |
526: TRAP1 is responsible for the co-translational regulation of BRAF and the downstream attenuation of ERK phosphorylation and cell cycle progression: A novel molecular target for human BRAF-mutated colorectal carcinomas
|
Sisinni, L. |
|
2014 |
50 |
S5 |
p. S127- 1 p. |
artikel |
860 |
13: Tumor heterogeneity and cell-of-origin of mouse small cell and non-small cell lung cancer
|
Berns, A. |
|
2014 |
50 |
S5 |
p. S4-S5 2 p. |
artikel |
861 |
687: Tumor-infiltrating lymphocytes in human gastric cancer and disseminated tumor cells
|
Osinsky, S. |
|
2014 |
50 |
S5 |
p. S165- 1 p. |
artikel |
862 |
274: Tumor metabolism and docetaxel resistance in prostate cancer
|
Taddei, M. |
|
2014 |
50 |
S5 |
p. S65- 1 p. |
artikel |
863 |
145: Tumor microenvironment influencing 18F-FDG uptake – an in vitro study in three different colorectal carcinoma cell lines
|
Abrantes, A. |
|
2014 |
50 |
S5 |
p. S32- 1 p. |
artikel |
864 |
596: Tumor miRNA expression profiling to identify circulating miRNAs for breast cancer detection
|
Matamala, N. |
|
2014 |
50 |
S5 |
p. S144- 1 p. |
artikel |
865 |
625: Tumor-stroma cross talk and cancer progression in breast cancer is related to tenascin-C expression
|
Kronberger, C. |
|
2014 |
50 |
S5 |
p. S149- 1 p. |
artikel |
866 |
63: Tumour–stroma interactions in breast cancer progression
|
Isacke, C. |
|
2014 |
50 |
S5 |
p. S16- 1 p. |
artikel |
867 |
272: TWIST1 and ZEB1 EMT inducers contribute to melanoma development through regulating MITF
|
Richard, G. |
|
2014 |
50 |
S5 |
p. S64- 1 p. |
artikel |
868 |
295: Twist oncoproteins are modulators of cellular stress
|
Kolodziejski, J. |
|
2014 |
50 |
S5 |
p. S70- 1 p. |
artikel |
869 |
498: Two distinct antitumor pathways activated by transfected poly(I:C) in androgen-independent prostate cancer cells
|
Palchetti, S. |
|
2014 |
50 |
S5 |
p. S120- 1 p. |
artikel |
870 |
257: TXNRD2 and DCBLD2 are novel targets of osteosarcoma metastasis
|
Topkas, E. |
|
2014 |
50 |
S5 |
p. S60- 1 p. |
artikel |
871 |
767: Ubiquitinated protein accumulation: A novel approach to treating bladder cancer
|
Sato, A. |
|
2014 |
50 |
S5 |
p. S184- 1 p. |
artikel |
872 |
476: Understanding and targeting PI3K pathway downstream of Met oncogenic mutant
|
Hervieu, A. |
|
2014 |
50 |
S5 |
p. S115- 1 p. |
artikel |
873 |
375: Understanding estrogen receptor transcription in breast cancer
|
Carroll, J. |
|
2014 |
50 |
S5 |
p. S89- 1 p. |
artikel |
874 |
31: Understanding transcriptional regulation of myeloid cells in the tumor microenvironment
|
Schultze, J. |
|
2014 |
50 |
S5 |
p. S8-S9 2 p. |
artikel |
875 |
67: Unexpected cancer-related properties of BRCA1
|
Hu, Y. |
|
2014 |
50 |
S5 |
p. S17- 1 p. |
artikel |
876 |
157: Unravelling the role of Caveolin-1 in metabolic reprogramming during hepatocellular carcinoma
|
Nwosu, Z. |
|
2014 |
50 |
S5 |
p. S35- 1 p. |
artikel |
877 |
673: uPAR and its interaction partners: potential new therapy targets in triple negative breast cancer
|
Huber, M. |
|
2014 |
50 |
S5 |
p. S161-S162 2 p. |
artikel |
878 |
220: Up-regulation of C1GALT1 promotes breast cancer cell growth through MUC1-C signaling pathway
|
Chou, C. |
|
2014 |
50 |
S5 |
p. S50-S51 2 p. |
artikel |
879 |
512: Urokinase modulates EGF-dependent signalling, proliferation and motility of the two breast cancer cell lines MCF-7 and MDA-MB-231
|
Kozlova, N. |
|
2014 |
50 |
S5 |
p. S123- 1 p. |
artikel |
880 |
986: Urolithins A and B, walnut polyphenol metabolites, modulate androgen receptor expression in a prostate cancer cell model
|
Sanchez-Gonzalez, C. |
|
2014 |
50 |
S5 |
p. S240-S241 2 p. |
artikel |
881 |
2: Using switchable mouse genetics to model cancer therapies
|
|
|
2014 |
50 |
S5 |
p. S1- 1 p. |
artikel |
882 |
238: Vascular endothelial growth factor-C modulates proliferation and chemoresistance in acute myeloid leukemic cells through an endothelin-1-dependent induction of cyclooxygenase-2
|
Yang, Y. |
|
2014 |
50 |
S5 |
p. S55-S56 2 p. |
artikel |
883 |
174: Vasoactive intestinal peptide decreases MYCN expression and AKT activity via a PKA-dependent pathway in neuroblastoma cells
|
De Boisvilliers, M. |
|
2014 |
50 |
S5 |
p. S39- 1 p. |
artikel |
884 |
364: VHL-dependent changes in global kinome expression in renal cell carcinoma
|
Rantanen, K. |
|
2014 |
50 |
S5 |
p. S87- 1 p. |
artikel |
885 |
124: Vincristine induces autophagy-mediated HMGB1 release via transcriptional regulation of Mcl-1 antagonizes apoptosis in human oral cancer cells
|
Yang, S. |
|
2014 |
50 |
S5 |
p. S27-S28 2 p. |
artikel |
886 |
417: Visualization of tumor formation in the WAP-TGFa/FGFR4Arg385 KI breast cancer mouse model
|
Sperl, B. |
|
2014 |
50 |
S5 |
p. S99-S100 2 p. |
artikel |
887 |
468: Whole-genome sequencing of Asian lung cancers: Second-hand smoke unlikely to be responsible for higher incidence of lung cancer among Asian never-smokers
|
Hillmer, A. |
|
2014 |
50 |
S5 |
p. S113- 1 p. |
artikel |
888 |
641: Whole-genome sequencing of plasma DNA reveals frequently occurring copy number changes in patients with metastatic breast cancer
|
Auer, M. |
|
2014 |
50 |
S5 |
p. S153- 1 p. |
artikel |
889 |
913: Whole thorax irradiation initiates a local and systemic accumulation of immunosuppressive FoxP3+ regulatory T cells
|
Wirsdörfer, F. |
|
2014 |
50 |
S5 |
p. S223- 1 p. |
artikel |
890 |
703: Whole transcriptome analysis of testicular germ cell tumors
|
Degoricija, L. |
|
2014 |
50 |
S5 |
p. S169- 1 p. |
artikel |
891 |
212: WIP, a novel negative regulator in WBP2-mediated Wnt pathway activation
|
Lim, S. |
|
2014 |
50 |
S5 |
p. S48- 1 p. |
artikel |
892 |
661: Wnt/β-catenin signalling inhibition decreases cell proliferation in Wnt autocrine-soft tissue sarcoma cells
|
Obrador-Hevia, A. |
|
2014 |
50 |
S5 |
p. S158- 1 p. |
artikel |
893 |
538: Wnt secretion is required to maintain Wnt activity in colon cancer
|
Voloshanenko, O. |
|
2014 |
50 |
S5 |
p. S130- 1 p. |
artikel |
894 |
27: Worldwide prevention of cervical cancer
|
Peto, J. |
|
2014 |
50 |
S5 |
p. S7-S8 2 p. |
artikel |
895 |
543: XIAP E3 ligase activity signals intra-mitochondrial processing of depolarized mitochondria to pre-empt intrinsic apoptosis
|
Hamacher-Brady, A. |
|
2014 |
50 |
S5 |
p. S131- 1 p. |
artikel |
896 |
934: XRCC1 Arg399Gln polymorphism and susceptibility for hereditary BRCA1/2 negative breast cancer in Serbian women
|
Krivokuca, A. |
|
2014 |
50 |
S5 |
p. S229- 1 p. |
artikel |
897 |
104: ZEB1 modulates expression of CDX1 and CDX2 caudal homeobox genes in colorectal carcinoma cell lines
|
De Barrios, O. |
|
2014 |
50 |
S5 |
p. S24- 1 p. |
artikel |
898 |
649: ZIRA: A new prognostic biomarker of estrogen receptor-positive (ER+) breast cancers
|
Vendrell, J. |
|
2014 |
50 |
S5 |
p. S155- 1 p. |
artikel |
899 |
143: Zoledronate suppresses human osteosarcoma (U2OS) cells invasion and migration by affecting cell morphology and cytoskeletal organization via FAK, RhoA, Ras, vimentin and E-cadherin
|
Lu, K. |
|
2014 |
50 |
S5 |
p. S32- 1 p. |
artikel |
900 |
312: Zoledronic acid impairs stromal reactivity by inhibiting M2-macrophages polarization and prostate cancer-associated fibroblasts
|
Comito, G. |
|
2014 |
50 |
S5 |
p. S74- 1 p. |
artikel |